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Abstract
1. A cDNA library was constructed with mRNA isolat.ed from
5tage 8 Xenopus embryos.
2. A f.ull length cDNA clone encoding a FGFR-l/flg gene '....as
isolated by screening this cDNA library. It is designated
XFGFR-A] .
). The XFGF'R-A3 clone was sequenced by dideoxynucleotide
chain terminati.on method on both strands with synthetic
oligonucleotides. It is 3863 bp in length and is predicted to
encode an 810 aa protein.
4. The XFGFR-AJ clone contains two dipeptide deletions, VaI4~.1.
Thr,I.~·l and ProH1SerH2, which are different from the published
XF'GFR-I sequence ( Figure 8 ). The Pro-l~ISer·142 deletion has
been described previously, however. this is the first report
of the Val·1.~-'-Thr~2~ deletion in Xenopus. Both dir,eptide
deletions result in the removal of consensus phosphorylation
sites for Protein Kinase C ( PKC ) which may have
consequences on intracellular signal transduction and the
regulation of embryonic development.
5. RT-PCR results showed that XFGFR-A) was expressed at all
stages of Xenopus embryonic development.
G. The RNase protection experiment showed that XFGFR-A3 is a
minor form of the XFGF'R-l in all stages of xenopus embryonic
development. Like the wild type XFGFR-l. XFGFR-AJ is also
uni formly expressed throughout Xenopus development.
7. The XF'GFR-AJ genomic DNA sequence covering the V'l' deletion
region was sequenced. The VT deletion is located at an
exon/intron boundary and comparison with the cDNA sequence
suggests that the XFGFR-A3 variant arises from the use of an
alten1<1te 5'splice donor site.
8. Expression vectors containing an insert covering the VT
deletion region fused to the eDNA encoding GST were
constructed by using XfGFR-A2 and XFGFR-AJ. A PKC assay using
the purified fusion proteins products showed that Thr4H of
XPGFR-A2 can be phosphorylated by PKC in vitro.
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Chapter 1
Introduction
1.1. Regional Specification-the Core Problem in
Embryonic Development Research
From egg to animal; from simplicity to complexity" "hrOIlCJh
more than a century of studies. embryologists now know thdt
different tissues and organs come from diE (erent. cells in th(~
embryo. The different cells in the elnbryo wore [n")11I
corresponding regions in the egg where cell differentiation
begins ( Davison, 1990 ), It is a series of rclcltively simplr!
developmental events that composed the whole r::mbryonic
development process. Each of these events is b.Jt>ed Oil th,·
former ones. The embryonic induction events, caused by c811-
cell interaction among different embryonic n'fJioIlS, play V(~r.y
important roles in embryonic development. RCf)iullal
specification, also called spatial organization or patt(~rn
formar:ion, was primarily caused by embryonic induction
events. As the core problem in current embryonic development
studies, regional specification studies C<A1l tell us how cell
differentiation occurs and hm.J body patterning forms during
embryonic development.
1.2. The Advantage of Xenopus laevis System
xenopus laevis is an ideal animal for developmental
studies:
II. Its eggs are large ( about 1.2 mm in diameter) and the
embryos develop externally, so it is relatively easy to do
micruinjection and microdissection.
2). Xenopus eggs may be obtained in large numbers which makes
it very easy to do most kinds of biochemical purification and
analysis as well as morphological experiments.
31. By in vitro fertilization, large numbers of homogenously
developing eggs can be obtained. In this way, the exact time
of fertilization can be known. Also, the Xenopus laevis
embryonic development stag~s have been well classified, thus
making it easier to monitor the development process .
.;1). Xenopus embryos develop very quickly. But the embryo
doesn't grow in size in the early stages. since Xenopus
embryos depend on their yolk for development, it is possible
to add interesting substances into the salt culture medium (
normal amphibian medium; NAM ) to test their potential
function in Xenopus embryonic development.
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1.3. Early Events of Xenopus Laevis Embryonic
Development
1.3.1. Facts About the Xenopus laevis Eggs
The unfertilized Xenopus eggs are radially symmetl".ic<11
about the animal-vegetal axis ( Gerhart, 1980 ). 1"01: eXcllllple,
there is a deep pigmentation on the animal hemisphere dnd the
animal hemisphere contains small yolk granules comp<lred tu
the vegetal hemisphere. The vegetal half has little pi<JllICllt
but many large yolk platelets. There are a few mRNA::~ ,1Ild
proteins specifically located in the animal or the vcget,ll
hemisphere during oogenesis. There is evidence that SOHle o{
the localized identified mRNAs and proteins have impOl"loml
roles in the early decisions of embryonic dev~lopull)l1t (
Lehmann and Nusslein-Volhard. 1986; Weeks et .'11 .. 19117,
Steward. 1989; Ephrussi.ec a1 .• 1991; Wang and Lehmann, 1991;
cheung et a1., 1992 I" The animal-vegetal azis is fonllcd
during oogenesis. but its origin is not known. ~;orne
experimental results have shown that the animdl-vegetal-azi~;
formation appears to involve selective transportJtion or
proteins and RNAs to the future vegetal pole ( Heasrnan Jnd
wylie 1984; Gerhart and Keller 1986; oanilchik and Gel-h,lrt
1987 ).
1.3.2. Events after Fertil.ization
1.3.2.1. Regional Specialization in the First
Cell Cycle
Before first cleavage, about an hour after fertilization,
the rigid e:ml:>ryo surface: cortex rotates by about 300 relative
to the inner cytoplasm ( Figure 1, Gerhart et al .• 1989 I.
1'his is a very important step in the establishment of dorsal-
ventral polarity. This cortical/cytoplasmic rotation
produces the grey cresent on the dorsal side opposing the
sperm entry site ( vincent et a1., 1986; Gerhart et a1
1989 ). In many species, the grey cresent results from the
visibility of pigmented animal cytoplasm through the rotated
vegetal cortex. The cortical rotation generates differences
in the dorsal and ventral cells which result in their
different abilities to induce a d('rsal axis (Gimlich and
Gerhart., 1984; Gimlich, 1986; Kageura, 1990 ). Cortex
rotation, which provides the dorsoventral specification. is
brou(lht about by cytoplasmic movements inherent to the
structure of the egg but not by the effect of sperm entrance
or gravity ( Gerhart, et a1., 1989 ). The importance of the
COl.'tical/cytoplasmic rotation was demonstrated by ultraviolet
{ UV I inadiation of the vegetal half of embryo. When the
,
vegetal hal': of the embryo is irrddidted I</ith 1I1tr~... ljlJlet
light before cortex rot<'ltioo, the rotation is inhibited (
Manes and Elison 1980; Vincent and Gerhdl't 1987 1. 'l'hc
resulting embryos can cleave and gastrulate but develop 110
dorsal or anterior st:t"uctures (Scharf and Gerhart 1980,
1983).
1.3.2.2. Early Xenopus Development Process
In the frog embryo, the fiI:"st cleavage ( Figure 1 ) betJill~{
at the animal pole and end at the vegetal pole and sepMdtr!~;
the embryo into right and left sides. The secund CleaVil()(~
also begins at the animdl pole and at right angles tn U"IC:!
first cleavage plane. At the four cell stage, the individlh) 1
cells have been pr-ogrammed for a different fute in thr~ f.utun!
body pattern. The third cleavage is along the equ,ltol',
separating al•. ,nal from vegetal hemisphere. The third Cl~ilVi.l<J(~
is slightly toward the animal pole resulting in smaller size·<1
cells in the animal hemisphere than those in thf~ vf:qr!tal
hemisphere. This size difference between animal <lnd ve'Jeta]
hemisphere cells is perpetuated throughout subsequ8nt
cleavages. As cleavage proceeds, a large central cavity
called a blastocoel forms surrounded by a layer of cell:;. 1'ho
embryo at this stage is called a blastula. The bl<:lGtula starJ(~
Figure 1. The Xenopus laevis embryonic development chart
measured in hours ( h I or days ( d J after fertilization.
Blastula stage occurs at 4 to 5 h af",er fertilization. (
Modified from Nieuwkoop and Faber staging table. 1975 )
\)
~~A~ ~ ~
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embryo undergoes extensive rearrangement called g<lstnlldtioll,
a process which transforms the vertebrate embryo dnd produces
a distinctive body plan with three tissue layet"s: ectodel'lll (
outer layer ); mesoderm ( intermediate lclyer ); elll'lodct"1l1 (
inner layer ). Gastrulation in Xellopus challges the bla!3tu 1,1
into a three layered structure wit.h anteroposterior ,111d
dorsoventral axes. These three germ layers will !Jive t'ise to
different tissues and organ systems in the adult dnimcll.
Ectoderm gives rise the nervous system and epidcnnis.
Mesoderm develops into cardiac and skeletal Illl1t4clc,
notochord, bone and cartilage, connective tissue, kidney
blood and mesenchyme. Endoderm produces the rJi !Jesti VI? l:.lO<ll.:t
and associated organs, such as liver and panel"eel(;. It i~; <1
series of induction events th.:lt control the <.ombryonic
development. One very famous experiment pet-fonned by Spell1,lllfl
and Mangold ( 1924 } showed that transplantation of d to:m.) I I
region of a gastrula stage amphibian embryo into d rH~W
location in a host embryo could induce the fonnation of ,J
second body axis in the host embryo. This small reI] lOll o(
embryo, located above the dorsal blastopore lip. is callc'u •
Spemann's orgnizer •. It can organize the rest of thr:- f,rnbryo
to develop the full dorsa-anterior axial structuH:S. 1'hn~r:
induct ion events were bel ieved to have irnportant ro I r:to: in
embryonic development. The first induction (:vent OCCUl""ro: in
the blastula stage and is called mesoderm inducton. The
second induction is called dorsalization and affects the
dorsal-ventral specification of the mesoderm ( Dale and
Slack, 1987 ). The third ind!.lction, also known as neural
induction, occurs during gastrulation and produces the
nervous system ( sharpe, 1990 ).
1.4. Mesoderm Induction
1.4.1. Mesoderm Induction and Models
The early blastula consists of animal and vegetal cells.
When in contac\,., vegetal cells induce animal cells to form
the mesoderm. This induction event is one of the earliest
cell-cell interactions to occur in amphibian development {
Green and Smith, 1990 l. The cells that will form the
mesodermal germ layer are located around the equator of the
embryo. It is generally believed that an inductive signal is
emitted from the ne .ghbouring vegetal hemisphere cells and
acts on neighbouring equatorial cells to induce them to
become mesodermal cells. The Xenopus mesoderm induction was
first described by· sudarwati and Nieuwkoop ( 1971 ). Their
findings demonstrated that mesoderm formation relies on an
interaction between animal and vegetal cells. When the
blastula stage embryo is C:issected and cultured, the animal
pole cells form epidermis only. while the vegetClI pole cello
form poorly differentiated endoderm. Howevel', ctlItlU.-cd
together, animal and vegetal pole cells can funD a variety o[
mesodermal tissues, Mesoderm has a dOl'sal·ventral polarity,
Work done by BOtere.lborond and Nieuwkoop ( 1973 I showed t..hat
vegetal pole cells from the dorsal side of the blilstul.l
tended to induce dorsal cell types such as notoehonl .1Ild
muscle while lateral and ventral vegetal blastomere:> induced
blood, a characteristic ventral cell type. alOllCJ with
mesenchyme and mesothelium. Ventral vegetal blastnm(~re~,
induce little or no muscle from animal pole cells. 'l'hi:.
demonstrat.es that at least two diffel'er.t types of induction
ventral mesoderm induction and dOl'sal me~odC:!nn
induction,
Slack and colleagues proposed a • three signal model- fOI"
mesoderm formation { Smith and Slack. 1983; Slack et dl.,
1984 I, In thill model, the first signal is releazP.d
uniformly from the ventral and lateral vegetal hemisphere,
creating a ring of ventral-type mesoderm in most of the
l.-luatorial zone. A second signal originating in the dorsal
vegetal region induces the formation of the most dorsal t.ype:
of mesoderm including Spemann' S organi zer, in the overlyin']
dorsal equatorial zone, The Spemtlnn's orgtlnizer sends a third
signal across the mesoderm to convert the initial ventral
mesoderrnal cells to a variety of different intermediate
mesodermal cell types. TodaY, more and more evidence suggests
that the format ion and patterning of mesoderm is the result
of a number of overlapping signals rather than three
spparated events, To expand the three signal model, a
synergistic model for meso"lp,rm induction was proposed (
Kimelman et al., 1992 ). This model emphasizes that the
inducing signals work synergistically. For example, FGF by
itself Cun only induce ventral mesoderm. By synergizing with
the Wnt-like facotrs, FGF can also induce dorsal mesoderm.
So in the synergistic model, the first step for dorsal
ventral patterning is i1ctivation of a k'nt-like factor by
cortical rotation in a broad dorsal region of the egg, with
maximlln activity at the dorsal midline of the equatorial
region. This activity can determine the competence of the
animal hemisphere to respond to mesoderm inducing signals
such as fGF and activin B.
1.4.2. Mesoderm Inducing Factors
The most extensive and comprehensive studies concerning
about the mesoderm induction events in amphibia were
completed within the past ten years. Slack et al. ( 1987 l
10
demonstri'lted that FGF can mimic the vegetal indllcllH) :>i'.]I1<11
and induce explanted tissue from Xenopus ellibryos to form
mesoderm. Another family of polypeptide growth facton; tll,ll'
have been implicated in mesoderm induction is the 'rCF-£ (
transforming growth factor-B l superfamily which inclu(ll2!s th,!
activins ( Smith, 19B7; Smith et al., 1990: 'l'homsen eoC .11.,
1990 ) and bone morphogenetic protein 4 ( BMP-<\ 1 ( Ko~·;t:el- <'I
ai., 1991: Dale et al. 1992: Jones et .'11., 1992 ).
The mesoderm-inducing CClPClcit~· of these ractnl's hLl~\ her111
tested primarily by addition of potential mesodel'm-inl1uc\n<j
factors to blastula stage explants of the animCll hemisphfnc (
the • animal cap • l which normally develop into ectodenOd I
tissues ( Smith 1987. J. These in vitro experiments helve
demonstrated t.hat FGFs t.end to induce vent.ral meSOd0T"m whi)e:
activin primarily induces dorsal mesoderm ( Slack et .1/.,
1987: Paterno etal., 1989; Smith, 1987; Smither. .'11. 1990l.
A second class of molecules. including Wnt ( Chrifjt.i~)n et
ai., 1991, Smith and Harland, 1991; Christian et al .. 1992
Noggin ( Smith and Harland, 1992 ) and lithium ( KilO et <11.
1986: Slack et al., 1988; KOla and Elinson, 1989 l differ!::
from the general mesoderm inducer families m~ntioneJ aboV(~.
They can not directly induce mesoderm on their o",m, in5tr:iuJ,
11
they modify the target cell's response to the mesoderm
indu,:ing factors. For example, FGF alone is not able to
induce notochord in ectodermal explants. but can do so in
combination \flith Xwnr.-B ( Christian er. al.. 1992; Kimelman et
al.. 1992 ). Wne family members can also cooperate with
activin ( Sokol and Melton, 1992 ). Mesoderm induction is
regulated temporally and spatially: both the appearan_e of
inducer molecules i1nd the acqllisition of competence, which is
the abiL.ty of a tissue to respond to the inductive signal,
are timed precisely in the appropriate region of the embryo.
It will be a crucial but difficult task to show which of
these factors are really involved in mesoderm induction
events during embryonic development. Criteria must be set for
the identification of the natural mesoderm inducing factors
and should include: 1. The potential mesoderm-inducing factor
must be expressed at a high enough concentration at the right
time, right stage. 2. The purified protein must show the
expected mesoderm-inducing function; 3. Blocking of the
factor should cause inhibition of the mesoderm induction in
vivo Of these three aspects, the last one is the most
difficult one to demonstrate. Mesoderm-inducing factors begin
to act as early as the 61\ cell stage. Because zygotic
transcription has not began sca=t at this time, mesoderm-
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inducing factor mRNA or protein must be present in the egg (
Shuttleworth and Colman, 1988; Slack e~ <~1., 1992 ). Evidence
to date suggests that many of the MIl's and modifyill<j {de tors
mentioned above have some role to pldY in mesoderm induction.
The work presented in this thesis is focussed on FCf and
mesoderm induction in Xenopus and, therefore. the rem<1imlel
of this intrOduction Io'ill be concerned with the FCFs ~lnd
their receptors.
1. 5. FGFs and Mesoderm Induction
1. 5.1. The FGF Family Members
The fibroblast growth factors ( fCfs ) are rnulti-ftinctioJldl
polypeptides that are expressed in a variety of embryonic dnJ
adult cell types and are involved in many irnport<lnL
developmental processes including embryonic induction 01
mesoderm, angiogenesis. chemotaxis, proliferation, and
neuronal maintenance ( Burgess and MilCi<lg, 1989; Ri[kin ,md
Moscatelli. 1989; Gospodarowicz, 1990 ).
fibroblast gro".. th factor was first identified ft'or~ hovinr:
brain extracts by its ability to stimulilte proli feration o[
BALB/c 3T3 fibroblat.ts ( GospodarOlolicz, 1974 J. NO'N thl": F(;l'
multlgene family is knmJO to consist of nine related mr:mbr;rs
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which are evolution.:1rily highly conserved ( Armelin, 1973;
Gospodaro...Jicz et a1., 1974; Michael et a1., 1992 ). These FGF
family members have 155-268 amine acids ( 110-150 KDa ) and
have 33-65 % homology at the amino acid level. As shown in
Table L The FGF multigene family members cloned so far
includes aF'GF ( FGF-l ) (Jaye, ec: a1., 1986 ), bFGF (FGF-2
) ( Abraham eC: a1. 1986 b.), int-2 (FGF-) ) ( Moore et a1.,
1986; Dickson and Peters, 1987 ), kFGF ( FGF-4, also called
ks/hst FGF ) ( Delli Bovi et a1 .. 1987 ). F'GF-5 ( Zhan et
a1., 1988 ), FGF-6 ( Marics et a1 .• 1989 2). KGI' ( FGF-7 ) (
Pinch et ai. 1989 l. FGF-8 ( Tanaka et al., 1992 ) and FGF-9
( Miyamoto et al., 1993 l. Another FGF called XeFGF. with a
unique expression pattern has been cloned from Xenopus
embryos recently ( Isaacs et al .. 1992 l.
The highest degree of similarity is between acidic FGF (
aFGF ) and basic FGF ( bFGF' ), the two oldest members of FGF
family, both can stimulate proliferation of cells of
mesenchymal, epithelial. and neuroectodermal origin. The cDNA
of acidic and basic FGFs encode 155 amino acid proteins with
55 % sequence homology. The ISS-amino acid protein is encoded
by three exons ( Abraham et a1., 1986 a, b ). aFGF aod bFGF
and FGF-9 are the only three FGF family members which lack a
hydrophobic secretion signal sequence located on the N-
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Table 1 FGF family members
aFGF ( FGF-1 J
bFGF (FGF-2 I
INT-2 { FGF-3 J
kFGF ( FGF-4, ks Ihst FGE" J
FGF-5
FGF-6
KGF ( FGF-7 I
FGF-8
FGF-9
XeFGF
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Jaye, et ill. 1986 J
Abrah<1m et a1., 1386 b. I
Moore et al., 1986 1
Dickson and Peters, 1987 )
Delli Bovi et a1., 1987 )
Zhan et a1., 1988 ,
Marics et al .. 1989 )
Finch et al., 1989 J
Tanaka et al., 1992 )
Miyamoto et a1., 1993 )
Isaacs et al., 1992 1
tr:rminal of protei:l. int-2 and hst/kaposi FGF ( kFGF ) are
proto-oncogenes products. int-2 FGF is expressed in the brain
of the adult mouse and its expression is developmentally
regulated during embryogenesis. kFGF is a proto-oncogene
product isolated from human stomach cancers and in Kaposi's
sarcoma. It is a 206 amino acid protein with 40 % homology to
bFGF. The int-2 and KFGF genes are located in close proximity
in the human and mouse genomes. They are co-expressed in
several human cancers. FGF~5 is a 268 amino acid protein
which was alse first identified as an oncogene product. FGF-6
is a 19B or 208 amino acid protein, depending on the
initiation site used. Keratinocyte growth flctor ( KGF ) is a
mitogen specific for epithelial cells. KGF recepcor can bind
RGF and aFGF with high affinity but binds bFGF with low
affinity. XeFGF is a new member of the fibroblast Qrowth
factor family isolated from a Xenopus lavis embryo eDNA
library. It is closely related to both mammalian kFGF ( FGF-4
land FGF-6. Two sequences of XeFGF were obtained that differ
by 11'1; at the amino acid level. This raises the possibility
that they represent pseudotetrapioid variants. ( Isaacs et
al., 1992 ). FGF-B, also called androgen-induced growth
factor ( AIGF ) was purified from a conditioned medium of an
androgen-dependent mouse mammary carcinoma cell line ( SC-3
). An FGF-B cDNA encodes a 215 aa protein with a putative
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signal peptide, and shares 30-40% homology with the knOl~l1
members of the FGF family. It has been shown that the
androgen-induced growth of sc-3 cells is mediated in all
autocrine manner by FGF-8, secreted by the tumor cel ~~
themselves in response to hormonal stimuli ( Tanaka et ell.,
1992 l. Glla-activating factor ( GAl" ) or FGF-9 is a novel
heparin-binding growth factor purified from the culture
supernatant of a human glioma cell line. Human fGF'-9 eDNA
clone encoded a polypeptide consisting of 208 amino acids. It
shares 30 % similarity with other members of the FGF family.
FGF-9 was found .0 have no typical signal sequence in its N
terminus like those in aFGF and bFGF. Both aF'GF and bFGF' are
known not to be secreted from cells in a conventional manner.
However, FGF-9 was found to be secreted from cells aEter'
synthesis despite its lack of a typical signal sequence. F'GF-
9 eDNA from rat has also been cloned. Its sequence is highly
conserved between rat and human. Expression oE the fGF-9 gene
could only be detected in the brain and kidney of the adult
rat suggesting that FGF-9 plays a different physiological
role from other members of fGf family (Hiyamoto et ill.,
1993).
There is 84 % homology between Xenopus and human bFGF I
Kimelman et a1., 1988 ) and 79% between Xenopus and human
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FGF'R 1 ( Friesel. R. and Dawid, LB. 1991 ). Both mouse and
human f'Gf' can interact with xenopus FGF receptors to induce
mesoderm in xenopus explants. Therefore, experimental results
obtained from studying the Xenopus system will provide useful
inforlTliltion for higher vertebrates.
1.5 .2. The Presence of FGF mRNA and Protein in
Xenopus Embryos
Both FGF protein ( Slack and Isaacs, 1989 ) and mRNA (
Kimelman et al., 1988 ) are present in the Xenopus embryo.
The first FGF eDNA clone was isolated by Kimelman and
Kirschner ( 1987 ) from a Xenopus oocyte library. This eDNA
clone contained sequences closely related to huni.::.n and bovine
bFGF. It was later shown that this eDNA clone contained just
a short open reading frame encoding a peptide domain
homologous to the third exon of mammalian bFGF; sequences
homologous to the first and second exons were missing. A 4.]
kb eDNA clone was isolated later and it encoded a protein of
155 amino acids and share 89 % identity with human bFGF at
the amino add level ( Kimelman and Kirschner, 1988 ). When
protein from this cDNA was synthesized in a T7 expression
system and purified by heparin-Sepharose chromatography it
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was shown to be as effective as r':>vine bFGF in inducing
muscle different.iat.ion from isolated Xenopus anill1dl caps.
TwO research groups have demonstrated that bF'GF pl'otein is
present in the Xenopus embryo ( Kimelman et al .• 1988; Slack
and Isaacs. 1989 I. By passing extracts from eggs clnd
blastulae through heparin-sepharose columns and eluting the
bound material with high concentrations of NaCl. Slack and
Isaacs ( 1989 1 showed that the eluted material had mesodet'm-
inducing activity. This activity could be blocked by
antibodies to bF'GF, but not to aFGF or: TGF-B. The active
fractions purified from HPLC heparin affinit't' column can be
recognized by an bFGF' antibody on Western J'lJots. It is
estimated that the total amount of FGF present in the Xenopus
embryo is bet.ween 7ng-70ng/ml. Iml1lunostaining by using
antibodies to both acidic and basic FGE' showed that both aFGF
and bFGF are present in oocytes and ea r ly embryos.
Immunostaining was predominantly intracellular and was
concentrated in the marginal zone and vegetal pole throughout
cleavage and blastula stages { Shiurba et al., 1991 l. Taken
together the evidence suggest that both FGF mRNA and protein
are present in Xenopus embryos and actively involved in
mesoderm induction in vivo.
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Vary ing sizes of bF'GF transcripts have been found in
different species ( Abraham et al., 1986 a, b; Kimelman et
ai., 1988 ). Different molecular weight forms of bFGF'
corresponding to approximately 18, 22.5, 23, and 24 KDa bFGF
protein can be translated from a single human bFGF mRNA
transcript ( Florkiewicz and Sommer, 1989; Prasts et al.,
1989 l. A 1.5 Kb bFGF' antisense transcript, which may have an
important role in the regulation of bFGF expression, was
found during Xenopus laevis oogenesis and embryogenesis (
Kimelman Clnd Kirschner, 1989; Yolk et ai. 1989).
1.6. Fibroblast Growth Factors Receptors
( FGFRs ) and Intracellular Signal
Transduction
1.6.1. Growth Factors and Tyrosine Kinase
Activity
Growth fClctors are crucial regulatory molecule!) for
multicellulClr organisms. Many growth factors are pleiotropic.
Most act by binding to and activating cell surface receptors
with an intrinsic protein tyrosine kinase activity. Most
receptor tyrosine kinase possess a large glycosylated,
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extracellular ligand binding domain, a single hydrophobic
transmembrane region, and a cytoplasmic domain that contains
a juxtamembrane domain and a tyrosine kinc1se catalytic
domain. The tyrosine kinase domain is the most highly
conserved portion of all receptor tyrosine kinase molecules.
It contains a consensus sequence Gly X Gly XX Gly X ( 15-20 )
Lys ( Yarden and Ullich, 1988; schlessinger, 1988; Hanks et
al., 1988 ) for binding ATP, The transmembrane domain o(
receptor tyrosim~ kinases is separated from the cytoplelsmic
catalytic domain by juxtamembrane sequences that vary ft-om
receptor fami ly to fami ly, but are conserved between rnemben-;
of the same receptor family subclass. It has been suggested
that this juxtamembrane region is involved in the regulelt iOIl
of receptor function ( Ullrich and Schlessinger, 1990 ).
Some recent experimental evidence indicates thelt till'!
protein tyrosine kinases ( PTKs ) have a important role in
developmental processes including migration, prolife.-ration
and differentiation. Many of these PTKs have been shown to be
expressed at high levels during embryonic development in a
localized region and at much higher levels than are r~y.pnlssed
in adults ( Pawson and Bernstein. 1990), Normal function o(
certain PTKs has been shown to be crucial to nonnal
development ( Pawson and Bernstein, 1990 ) as disro;ption ot
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PTK function during embryogenesis can result in major
phenotypic changes.
Ligand binding to the extracellular domain of a growth
factor receptor induces receptor dimerization, resulting in
receptor autophosphorylation by an intermolecular mechanism (
Ullrich and Schlessinger, 1990 ). Intracellular substrates,
which possess catalytic activity regulated by tyrosine
phosphorylation, then interact with and are phosphorylated by
the activated growth factor receptors { Figure 2 }.
Intracellular substrates that have been identified to date
include phospholipase c-y ( PLC-y ), p21ru, GTPase-activating
protein ( GAP I, Grb2 l Egan et C11., 1993; Li, N. et a1.,
1993 1, and the putative regulatory subunit of
phosphatidylinositol ( PI 1 3' -kinase ( p8S ) ( Cantley et:
a1 .• 1991 ). These substrates contain SH2 or SH) ( src
homology reg.:on5 2 or 3 ) domains, noncatalytic domains of
100 ael. conserved in a series of cellular signal transduction
proteins ( Cantley et al., 1991; Koch et: al., 1991 1. For
example, Grb2 in mammals functions by recruitirlg a Ras
activator. mSos, to the receptor to form a stable complex.
Recruitment of 50S1 facilitates Ras activation and subsequent
signal transmission down the Ras-dependent kinase cascade.
Grb2 binds to activated receptors by the SH2 domain, and to
22
Figure 2. Diagrammatic representation of receptor tyrosine
kinases and intracellular signal transduction pathways.
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50S by the 5H3 domain. Receptor-associated 50S provokes GDP-
G'l'P exchange on Ras triggering a cascade of serine-threonine
kinases that send trophic signals to the nucleus.
1.6.2. FGF Receptor Signal Transduction Pathway
1.6.2.1. High Affinity and LO\'l Affinity FGF
Receptors
E'GE's rely on FGF receptors ( FGFRs ) to transmit the
signal across the plasma membrane. There are two types of
F'GFRs. Low affinity binding sites, represented by heparan
sulfate in the extracellular matrix or on the cell surface
and high affinity binding sites, represented by transmembrane
receptors ( Burgess and Maciag 1989 ). FGF binding to heparan
sulfate is a pre-requisite for interaction of FGF with high
affinity transmembrane receptors. In the extracellular
matrix. soluble heparan sulfate molecules can serve as a FGF
cllrrier to protect it from being proteolysed ( Folkman. et
~11 .• 1988 ).
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1.6.2.2. Structure of High Affinity FGF
Receptors
FGF receptor tyrosine kinases are similar to othel' qrowth
factor receptors such as the platelet-derived growth [dctOI' (
PDGFR 1 receptor and the epidermal grO\~th fclctor n~ceptof' (
EGFR ). The unique features of the FGF receptor tyt·osi ne
kinase are as follows: an extracel1ul~lr region with th1"fw' 1\.1
immunoglobulin )-like domains, a reldtively lOll!]
juxtamembrane region, a kinase catalytic domdin r::plit Uy dIll
amino acid sequence and a short carboxyl tel"l11in,11 teli I (
Michael et al., 1992 l.
All high affinity FGF rp.ceptors encode a tl'an~mt':1nbl'dn':
protein which consists of 800-822 amino acids with 6-9 tl·
linked glycosylation sites in the ey.tracelluldr doulclin. 'rlH: tl-
terminus contains a 18-24 amino acid signal ::a."qU/:n':l":,
followed by a 346-356 amino acid excraceJ lUilr dOlflaill
containing three 19-1ike ( 19 I domains with a vl?ry oJciiJi,;
region between first and second Ig-like dOlllain. 1'h0 2] alllinu
acid transmembrane domain is followed by a 1\ 10-1\25 ami r.o .:II:" iii
cytoplasmic domain consisting of 74-81 ami-no ,)r;irl
juxtamembrane region, the intrac~llul.:H tyrosinr: kirl..:.r,;r~
domain with 14 amino acid insertion, and u carbr'l;.::yl-tf<l'rnindJ
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of 59-69 amino acid residues ( Figure 3 ).
1.6.2.3. FGF Receptor Dimerization and Receptor
Signal Transduction
The EGF receptor ligand binding induces the dimerization of
EGE" receptors. The EGF receptor dimerization causes EGF
receptor conformational change and leads to receptor
autophosphorylation in the cytoplasmic region by an
intermoleclliar mechanism ( Ullrich and Schlessinger, 1990 ).
This results in EGE" receptors higher ligand binding affinity
and elevated protein tyrosine kinase activity. It is
speculated that the same mechanism is used by FGFR. FGF
receptor tyrosine kinases catalyze the phosphorylation of
tyrosine residues on their awn intracellular domains as well
as on substrates ( Honegger et a1., 1989; Ballotti et: a1.,
1989 l. Of the known intracellular PTK substrates only
phospholipase c-y ( PLC-y ) has been shown to intetact with
the FGFR. Sllbstt'ate PLC-y can catalyze the breakdown of the
membrane phospholipid, phosphatidylinositol bisphosphate to
inositol l,4,5*triphosphate ( IP., ) and diacylglycerol ( DAG
). These second messengers, as well as other serine/threonine
26
Figure 3. Diagrammatic representation of the FGFR structure.
sp" signal peptide, 1= first Ig·like domain, AR: dcidic
residue cluster, lIz: second Ig-like domain. 111= thil'd 1(1-
like domain, TH= transmembrane region, JM= juxtamembl·dm~
region, TKI= tyrosine kinase domain I. KI= kindse insert
sequence, TKII= tyrosine kinase dOll\ilin II.
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protein kinase can release calcium from intracellular
and activated protein kinase C ( PKC ).
1.6.3. FGF Receptors in Xenopus Embryonic
Development
1.6.3.1. FGF Receptor Family Members
The FGF receptor was originally isolated from chicken
embryos ( Lee et al., 198~ I and shown to have homology to a
partial human cDNA clone which had been named fIg ( fros-like
gene ) ( Ruta et al., 1988 ). Since then FGFRs have been
cloned and characterized from chicken, human, !:louse and
Xenopus ( Michael et aI., 1992 I. To date four different
FGPR genes, fig ( fms like gene) or FGFRI ( Ruta et al.,
1988 I, bek ( oocterial expressed kinase ) or FGFR2 ( Dionne
ill., 1990 I, FGFR3 ( Keegan et al., 1991 ), FGFR4 as well
as a number of receptur variants have been cloned Table
2; Michael et al., 1992 ). These FGF receptors encode
proteins that have 800-822 amino acid residues and share 56-
92 % identity at the amino acid level.
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Table 2. FGFR fami ly members
FGFR1/flg(fms-like gene}
FGFR2/bek (bacterial expressed kinase)
FGFR3
FGFR4
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Ruta et <11 .• 1988
Dionne et ,~l .. 1990
Keegcln et a1., 1991
Machael et dl., 1992
1.6.3.2. FGF Receptors and Mesoderm Induction
Current evidence indicates that FGF and the FGFR
signalling system are involved in mesoderm induction events
in xenopus embryonic deve).opment ( Amaya et al., 1991;
Jessell et ..'11., 1992; Kimelman et a1. 1988; Slack et a1.,
1987; Whitman and Melton, 1992; Ryan and Gillespie 1993,
submitted l. PGFs, such as bFGF, int-2 and XeFGF, can mimic
the mesoderm-inducing activity of vegetal pole cells in the
early blastula and, hence, mdY be a component of the natural
inducer ( Slack et a1., 1987; Kimelman et a1., 1988 ). The
FGFRl is ::lctivated during mesoderm induction by vegetal cells
pI"oviding direct evidence that FGF is a component of the
vegetal inducing signal ( Ryan and Gillespie 1993, submitted
). 'I'he importance of FGFR signalling in e-mbryonic development
was recently demonsLrated by Amaya et a1., ( 1991 l. These
investigators demonstrated that the injection into embryos of
cRNA encoding a dominant-negative mutant form of FGFRI that
lacks the intracellular tyrosine kinase domain can cause
significant reduction in mesodermal structures of tadpoles.
Explanted animal pole ectoderm derived from embryos
expressing the truncated receptor failed to form mesoderm in
response to FGF-2. This effect could be reversed by forced
overexpression of the wild-type receptor. These data clearly
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demonstrate an important role for the FGFs and their
receptors in embryonic mesoderm formation HOI~ever, the
mechanisms by which this occurs remains to be eluciddted (
Amaya et al., 1991 )
1.6.3.3. The Expression Pattern of FGF
Receptors
Distinct patterns of expression of each FGF' receptor were
found in different species, and tissues, suggesting u
functional specificity. Recent studies show that PGrRII [/y
mRNA were highly expressed in the migrating embryonic
mesoderm of gastrulation mouse embryo ( Yamaguchi et ..11.,
1992 1.
Affinity labelling was used to detect the presence of FGFH
protein on the surface of different types of cells. Two m.::ljor
bands, 125 Kd and 145 Kd, were identified in most cell types.
The 145 Kda protein had a higher affinity for bFGF, while the
125 Kda protein had a apparently higher affinity for aFCF (
Neufeld et al., 1986 1. Two FGF receptors ( 130 kd, lilO kd
respectively ) were identified in Xenopus blastula by ur.inrJ
the same approach ( Gillespie et al., 1989 ). D(~spite thr!
fact that cDNA clones of four distinct FGFR gener; hay(~ b(~en
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characterized, ~t remains unclear whether these two FGFR
proteins on cell surface are the products of different genes,
alternatively spliced products of the same gene or result
from differences in post-translational modifications, such as
glycosylation.
1.6.4. FGF Receptor Variants
Alternative splicing gives rise to a number of FGFR
varicmts ( Burgess and Maciag, 1989; Jaye et al., 1992 ). The
mcljor flg variants include: deletions or insertions in the
extracellular membrane domain; deletions in the cytoplasmic
domain; flg variants encoding a secreted form; or,
intracellular domain variants. A two-Ig form of flg has been
found in a variety of tissues and species. One of the flg
variants contains a VT-dipeptide deletion in the
juxtamembrane region. This VT dipeptide deletion is also
found in bek and FGFR-4 ( Jaye et al., 1992 ). Potential
secreted forms FGFR-Elg which possess either one or three 19-
like domains have been reported. Those secreted flg variants
do not have the cytoplasmic portion of normal fIg, but they
have 31 irrelevant amino acid residues immediately downstream
of Ig-like domain ( Eisemann ec aI., 1991 ). It has been
shown that the ligand-binding specificity is located on the
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second exon half of third Ig-like domain ( Werner et .'11.
1991 ). Intracellular domain variants includes insertion in
the tyrosine kinase domain and truncated form of tyrosine
kinase domain. similar variants have also found in belL 50\l1e
of flg and bek variants involved use of alternative exons (
Jaye et a1., 1992 ).
1.6.5. FOF Receptors in Xenopus laevis
Xenopus fGFRs have similar structure to FGFRs from other
species. So far, eDNA representing two different F'GFR genes
have been cloned from xenopus ( Musci ee a1., 1990; Friesel
ee all 1991; Friesel and Brown, 1992 ). They represent the
Xenopus homologue of FGFRI ( flg ) and FGF'R2 ( bek I. FGFRI
is expressed throughout all developmental stages and F'GFR2
only expressed after post-gastrulation ( Ruta ee cd., 1988;
Dionne ee ai., 1990 1. One of the Xenopus FGFRls ( designated
XFGFR-Al ) was cloned from a eDNA library constructed from
the Xenopus XTC cell line. ( Friesel ee ai" 1991 ). The
other one ( XFGFR-A2 I was isolated from a Xenopus oocyte
CONI'. library ( Musci ee al., 1990 ). The two XFGFR5 are 95'1;
homologous. Friesel ee al.. also isolated another XFGFR-A2
variant which is identical to the sequence Musci ee al.
cloned except for an 88 amino acid deletion at N-terminus.
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There are evidence suggest that FGF is involved in mesoderm
induction in Xenopus embryonic development ( Slack et al,
1987; Gillespie et a1, 1989; Amaya et aI, 1991; Ryan and
Gillespie, Submitted ). It has also been reported that
different concentrations of FGF can induce different mesoderm
tissues ( Smith and Slack 1983; Slack. et al., 1984 ; Slack
et aL 1987; Gillespie et aL 1989; Kimelman. et ai., 1992 ).
Therefore, it is very important to understand the different
responses mediat8d by FGF /FGFR signaling system during the
mesoderm induction process. There are several mechanisms
which FGF/FGFR signaling system might use to generate
different intracellular signals. One of those is that
FGF/FGFR signaling system generate di f ferent
intracellular signals by regulating the availability of
various members of the FGFR family in different cells
embryonic tissues ( Patstone et ai., 1993 ).
So far, all xenopus FGFR were cloned from oocytes or cell
lines. No FGFR has been cloned from Xenopus embryos. The
interest of this thesis work is to isolate and analyze FGFR
cDNA from the developmental stage when mesoderm induction
occurred. The experiments presented here were designed for
cloning and characterization of one XFGFR-1 variant, XFGFR-
"3, isolated from Xenopus embryos.
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Chapter 2
Materials and Methods
2.1. Materials
Restriction endonucleases were purchased ft'om Bethesdd
Research Laboratories I GIBCO-BRL, Li fe Technology, Inc.
Burlington. ON. Canada }, New England Biolabs, Inc.
Berverly, MA. USA I, or Boehringer Mannheim Cancldil ( Ldvdl,
Quebec) .
T4 DNA ligase, RNas..:: A, RNase Tl, calf intestinal alkaline
phosphatase I ClAP J and reverse transcriptase were purchc1sed
from GIOCO-BRL or Pharmacia Fine Chemicals ( Piscataway, NJ.
USh I. Buffers for above enzymes were supplied by the
manufacturer, The purified PKC was from Upstate BiotechnolOfJY
Incorporated I Lake placid, NY. USA.).
The Xenopus recombinant bF'GF' was expressed in E.coli and
purified by heparin-Sepharose chromatography as described in
Kimelman et: a1 { 1988 1.
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Kodak XAR-5 X-ray film was purchased from Eastman Kodak
Co. ( Rochester, NY. USA. l.
The radioactive [a-j~plUTP, [a-35sjdATP, [a-npjdATP and
[1- JJp]dATP were purchased from Amersham Canada Limited (
Oakville. ON. Canada l.
Electrophoresis grade agarose was from GlBCO-BRL.
Acrylamide, bisacrylamide, TEMED, and ammonium persulphate
were products of Bio-Rad Laboratories ( Richmond, CA. USA. ).
The pcDNAl neo-plasmid containing XFGFR-A2 clone was kindly
provided by Dr. R. Friesel. The KS(t) plasmid containing the
ODC fragment was a gift from Dr. J.M.W. Slack.
Bacto-tryptone, bacto-agar and yeast extract were bought
from BOH. LB, NZY media, and LB/Ampicillin were prepared as
described in Maniatis et al., ( 1989 ). Ampicillin and
tetracycline were purchased from Sigma Chemical Co.,
St.Louis, MO, USA.
The E.coli strains SURE and XL-BLUE were from Stratagene.
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La Jolla, CA USA.
2.2. Methods
2.2.1. Embryos, Dissections and Induction Assays
Xenopus embryos were obtained by artificial fertilizcltion.
handled and dissected as previously described by GodsClve et
ai., ( 1988 ) and staged according to NieLlwkoop and Pabel' (
1975 l. female xenopus iaevis were induced to lay eggs by
subcutaneous injection of 500 I.U. of human chorionic
gonadotrophin in 0.5 ml dH10. The eggs subsequently obtclined
were fertilized using ground Xenopus testes. Following
rotation of the eggs, the jelly coats were removed using 2. '5
, w/v cysteine hydrochloride { Sigma Chelllical Co. St LouS,
MO. USA. 1 adjusted to pH 7.8-8.1 with NaoH. They were then
washed throughly and allowed to develop in petri dishes
coated with 1.5 1 agar ( Ditco, Detroit, HI. USA. ) in 1/20
normal amphibian medium ( NAM. Table 3; Slack and forman,
1980 ).
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Table 3. Composit i.on of the NAM { Normal Amphibian Medium}
used in the exper lment.
lOX NAM salts
NClCI
KCl
Ca(NO.l)2·4H~O
MgS04· 7H20
ED'TA { O.5M, pHS}
Hepes ( 1M, pH7. 5 )
Ix solutions
g/l
( in lOx stock)
65
1.5
2.'
2.5
2m.l.s
lOOmIs
mM
( Final in IX )
110
2
1
1
0.1
10
Par 100 mls of solution, add:
NAM NAMI2 NAM/20
lOx NAM salts 10 mls 5 mls 0.5 mls
Gentamycin 0.25 0.25 0.25
N. Bicarb. 1 1
Sterile H2O 88.75 93.75 99.25
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2.2.2. Total RNA Isolation
RNA was prepared from whole embryos or animal Cilp explclnt$
by the LiCl!Urea method. This extraction method selectively
precipitates RNAs with a high concentration of Liel whi 1e
small RNAS and DNA remain soluble. Proteins at'e del\c1tunxl cmd
solubilized by the presence of 6 M Urea. To 100 embryos. :::!. 'j
ml of extraction buffer ( ) M Licl, 6 M Urea. 10 mM NaoAC pll
7.5, 0.1 % 50S, 0.5 % 2-mercaptoethanol 1 We)S cldded. 'l'h(~
embryos were then homogenized and sonicilted to She,H" DNA. 'I'he
mixt:ure was left on ice overnight to selectively pn~cipjt:,H.()
RNA. RNA was pelleted by centrifugation of the OVE't·nl'.lllt
mixture at 12, 000 g for )0 minutes. The HNA pell (:t
resuspended in O. 3M NaOAc pH 7.5 containing 0.5 Y; 80S dlllJ
extracted with phenol/chlorofonnl isoamyl Gllcohol ( 1
0.02 ). After ethanol precipitation, the concentration ol the
RNA was determined by measurement of absorbance at 260 nm allll
280 nm. The integrity of the RNA WClS verified by
electrophoresis on a 1 % agarose gel conta in in<j 1 M
formaldehyde buffered with 50 mM HEPES/EDTA pH 6.5. 'I'ot,~1
RNAs prepared by this method are good for mRNA purifi.ciltion,
RT-PCR, and RNase protection assays.
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2.2.3. mRNA Isolation
The quality and quantity of the mRNA used is of fundamental
importance to the construction of a large, representive CDN.:"
library. The polyAtract mRNA isolation kit ( Promega
FisherScientific. Toronto, ON. Canada) was used to quickly
produce a large quantity of undegraded RNA. mRNA isolation
was perfol"med according to the instructions provided with the
Poly~.tract kit. It is based on the magnetic separation of
mRNA bound to oligo-dT particles from the total RNA
population. Total RNA was dissolved in RNase-free water to
give the desired concentration and annealed to biotinylated-
oligo(dT) at 65"C in annealing buffer 0.5xSSC ).
Streptavidin paramagnetic particles ( SA-PMPs ) were washed
with O.SxSSC added to the annealing mixture and then
incubated at l'oom temperature for 10 minutes to allow the
stl'eptavidin to bind the biotinylated complex. The SA-PMPS-
biotinylated-oligo (dT) mRNA complex was pelleted using the
magnetic rack and the supernatant was carefully removed and
disciu·ded. The mRNA-containing particll::!s were washed with
o .1xSSC and the captured mr.NA was released by resuspending
the final SA-PMP pellet in RNase-free water. The mRNA
prepared in this way was of the high quality necessary for
eDNA library construction.
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2.2.4. Construction of cDNA Library
2.2.4.1. General Information
A cDNA library was constructed with mRNAs Ct"OIO ~a:<l(Jc fl
Xenopus embryos and a A-ZAP cDNA synthesis Kit I Stl"dtd~lellp.,
La Jolla, CA. USA ). An outline of Strdtaqene's ZAP eDNA
synthesis kit is provided ( Figure 5 ). A df:!til i led
description of the steps involved ill the construction of tlK'
cDNA library is provided in the followinl] section!';. lll"iefly,
fir:=;t strand eDNA was synt.hesized frOIn 2 I.Ig of mRNA (I-Olll
stage 8 embryos with oligoldT)-adaptors containing XhoI <wI!
SpeI restriction sites. 5-methyl dCTP was incorpor<ltr~d into
the second strand to ensure that the restriction sites j n the
linker-primer were susceptible to restriction digestion. 'J'he
uneven termini of the double-stranded cDNA was nibbled bclck
or filled in with T4 DNA polymerase and EcoRI adaptors wr:n~
ligated to the blunt ends. After XhoI digestion, the cDl~M;
were directionally inserted into A Uni-ZAP XR v(:ctor ann~ (
Stratagene ) and packaged into a high-efficiency r;ystem, thf:
Gigapack II Gold packaging extract. The packaqed products
were plated on SURE E.coli ( mcrA- and mcrB- strain J tl) qjvr:
the primary cDNA library ( unamplifif:!d libra["y ). Thf~ [j mt
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figure 5. The cDNA library construction chart ( From Stratagene
eDNA Libraries Construction Kit Chart I.
Firststr~ndsynthtsiswithmtthylnucltotkjes
5' -_- - AAAAAAA:
TTTTTTl Xho Ispe/ I S'
Revtrse tr.lnsaiptase and Rnase block
Package library and plate on PLK·F' cells
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amplified cDNA library was obtained by plating the prim.n'y
cDNA library on the XL-Blue E.coli strain.
2.2.4.2. First Strand Synthesis
First strand cDNA synthesis begins when reven;e
transcriptase, in the presence of nucleot ides and the
appropriate buffer, finds a template and primer. The template
is messenger RNA and the primer is a fifty base oJil]o
consisting of "GAGA" protection sequences, XhoI ilnd SpeJ
restriction enzyme recognition sites, and an 18 baBe poly
(dT) sequence ( Table 4 ).
In an RNase-free microcentrifuge tube, the fall owi.n\J
reagents were added: 5.0 III lOx first strand reaction buf(f:r,
.3.0 III 10 mM first strand reaction methyl nucleotide mixtu,'e,
2.0 III linker-primer ( 1.4 1l91l1l ), 30 III DEPe-treated watN,
and 1.0 J.LI RNase Block II ( 1 uilil ). The reagent::; W8re
vortexed to ensure all the components are well mixed. Thrm 5
I1g mRNA from stage 8 Xenopus embryos ( in 6.5 III DEPC-t reoltr~d
water ) was added. The template and primer were aJ low~d to
anneal for 10 minutes at room temperature. Then 2.5 III of H·
MVRT was added. The sample was gently vortexed and spun do~m
in a microcentrifuge. 5 III of the mixture was trrJnsferred
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Table 4. Sequences of polylinker and primer used in the eDNA
library construction.
Name
Poly linker
Primer
Sequence
5 'AATTCGGCACGAG 3'
3 'GCCGTGCTC 5'
5' GAGAGAGAGAGAGAGAGAGAACTAGT
CTCGAGTTTTTTTTTTTTTTTTTT 3'
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Figure 4. Autoradiograph showing the synthesis of high
quality first and second strand cDNA from mRNA of stage 8
Xenopus embryos by M-MLVRT. The cDNA were used for cDNA
library construction. Lane 1 and 2 show the parallel loading
of the first strand cDNA product. Lane 3 and 4 show the
parallel loading of second strand cDNA synthesis. Samples
were separated by alkaline agarose gel electrophoresis ( See
methods section for details ).
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into a separate tube containing 0.5 III of the (<x-,np]dNTP (
aoo Cilrnmole ). This 5 III of first strand radioactive control
sample allowed the analysis of the quality and quantity of
the first strand synthesis. Both mixtures were incubated at
37"C for 1 hour. After 1 hour incubation. The first strand
synthesis reaction mixtures were removed from the :noc bath
and stored at -70"C. The radioactive first strand control was
later used for anaysis of first strand synthesis (Figure 4.).
2.2.4.3. Second Strand Synthesis
In the 45 III first strand reaction mixture. the following
t"eagents were added: 40 III lOx second strand reaction buffer,
6 III 10 mM second strand reactiom nucleotide mixture. 300 III
dH.:O and 2 III {a-j·~pl dNTP ( BOO Ci/mmole ). The sample was
briefly vortexed and the following enzymes was added: 0.9 III
RNase H ( 4 U/Ill ) aoc 6.7 III DNA polymerase I ( 10.0 U/1l1 ).
The t.ube was quickly vortexed and incubated for 2.5 hours at
16"C. The t.ube was placed on ice immediately after synthesis.
The mixture was extracted with an equal volume of
phenol/chloroform and the aqueous layer was re-extracted with
chloroform. The upper aqueous layer was transferred into a
new tube. CDNAS were precipitated by adding 34 III of 3M
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sodium acetate and BBO ~l of 100 % ethanol to the t'eal:ion
mixture. The ethanol precipitation was spun down. and pellet
gently washed with 1 ml of BO % et.hanol. After W<lShiIlIj,
the pellet was resuspended in 4].5 ~l of dll.:O. '.1.5 ~tl WiW
removed and frozen at -:lOne for later ane.lysis of second
strand synthesis quality ( Figure 4 ).
2.2 .4 .4. Blunting the eDNA Termini
In the tube containing 39 ~l second strand rf:!dCt ion
mixture. the following reagents were added: 5 ~l IOx'T'4 DNA
polymerase buffer. 2,5J.ll 2.5 mM dN'T'P mix and ).5 III 1'01 DNA
polymerase ( 2. 9 u/~l l The tube was incubated elt )7"C for )0
minutes. Then 50 1.1.1 dH.~O was added to bring the volume up to
100 1.1.1. The sample was extracted with an equal volume of
phenol/chloroform followed by re-extraction with em equ<11
volume of chloroform. The aqueous phase was transfer into <1
new tube and precipitated by adding 7 ~l of )M sodiUlr acetate
and 226 ~l of 100 % ethanol. The ethanol precip'tation
spun down. Pellet was washed with 150 III 80 % ethanol.
2.2.4.5. Ligating EcoR I Adaptors
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The p~llet was resuspended in 7 ~l EcoR I adaptors followed
by adding the following reagents; 1 ~l lOx ligase buffer, 1
}J.l 10 rnl.f ATP, and 1 1.11 T4 DNA ligase. The reaction mixture
was incubated overnight at 8"C. The ligase was inactivated by
placing the tubes in a 70 llC water bath for 30 minutes.
2.2.4.6. Kinasing the EeoR I End and Xho I
Digestion
The following reagents were added into the tube containing
the heat inactivated ligation mixture: 1 III lOx ligation
buf fer, 2 1.11 10 mM ATP, 6 1.11 dH.,O, and 1 1.11 T4 polynucleotide
kinase ( 10 U/}J.l ). The tube was incubated for 30 minutes at
37 l1C. The kinas..: was inactivated by heating for 30 minutes at
70(IC. The reaction mixture was cooled to room temperature. 28
J.ll xho I buffer supplement and 3 1.11 xho I ( 45 U/1.l1 ) were
added. The tube was incubated for 1.5 hours at 370C followed
by adding 5 1.11 lOx STE buf fer. The sample was loaded onto a
ready-co-go 5ephacryl 5-400 Column and was spun in a table
top centrifuge for 3 minutes at 700xg. The first fraction
which contains !.arge cDNAS was collected. 60 1.11 of Ix 5TE was
loaded onto the column and was spun again to get second CDNA
fraction. The pooled cDNA fractions were extracted with an
equal volume of phenol/chloroform. The upper aqueous layer
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was transferred into a ne\~ tube and re-extracted follOl~ed by
precipitating the eDNA from the aqueous layer with 2x volume
ethanol. The eDNA was resuspended in 10 1.11 dH~O.
2.2.4.7. Ligating cDNA into Vector l~rms
The following reagents were added into the tub~ cont<lininu
2.5 1.11 of resuspended eDNA: 0.5 1.11 lOx ligation buffer, 0.5
1.11 10 mM rATP, 1.01.11 Uni-ZAP XR vector ( 11.19/1.11 ), and 0.5
III T4 DNA ligase ( 4 weiss U/J.lll The tube was incubated
three days at 40C followed by 2 hours at room temDel·olture.
2.2.4.8. packaging Instructions
1 J.l1 of ligation mixture was packaged into Gigapack II Gold
packaging extract according to the packaging instructiol1s. 1
J.ll of ligation mixture and 15 III sonic extract were added to
the tube containing quickly thawed packaging extract. 'fhe
tube was stirred and spun quickly followed by incubation at
room temperature for 2 hours. 500 1.11 phage dilution bufff:tr
and 20 I.ll chloroform were added. The tube was mix€:d g0ntly
and spun briefly to sediment debris. The supernatant ~}i1f;
stored at 40C and ready to be titered.
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2.2.4.9. Plating and Amplification of Uni-ZAP XR
Library
1 III of the diluted ( 1:10 dilution with SM buffer) and 1
III of the undiluted library were plated with 200 III of
OD(,on.,0.5 SURE cells separately. Phage and bacteria were
pre incubated for 20 minutes at 370<:. 3 ml of top agar ( 480C )
was added and plated irrunediately onto pt-ewarmed ( 370C ) NZY
agar plates. plates were incubated overnight at 370C. The
titer of this primary eDNA library was determined by counting
the plaques formed on plates. To amplify the primary eDNA
library. approximately 50.000 recombinant bacteriophage was
added into 600 1I1 of XL-BLUE cells adjusted to an 00600.,0.5.
The cells were incubated at 370C for 15 minutes. The cells
were then mixed with 6.5 ml of melted 480C top agar and poured
evenly onto a prewarmed NZY 150 rnm plate of bottom agar. The
plates were incubated at 37 IJC for 6-9 hours. 10 ml of SM
buffer was added onto each plate. The plates were incubated
at 4 {lC ov{~rnight with gently shaking or rocking. The
bacteriophage suspension was recovered from each plate and
pool into a sterile polypropylene or glass container. The
plates were rinsed with an additional 2 rol of SM and pooled.
Chloroform was added to the pooled suspension to 5 % followed
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by gently mixing. Cell debris was removed by centrifuging the
suspension at 4000 g for 5 minutes. The supernatant W<1!;1
recovered, pooled and transferred to a sterile polypropylene
or a glass bottle. Chloroform was added to 0.3 t and the
library was stored in aliquots at 4"C. The titel- of the
primary amplified library was checked by usin<) XL-OLUE eel La
and serial dilutions of the library.
2.2.5. Library Screening and eDNA Clone
Isolation
,., 400 bp DNA fragment corresponding to part of the tyrosim:
kinase domain of the xenopus F'GFR ( isolated by Gillespie,
Figure 98 ) was used to screen the eDNA library at low
stringency. The 400bp fragment was gel purified and labelled
with a random primer labelling kit ( BRL land (ct-J·:P]A'I'P (
>400 Ci/mmol: Ainersham ). The library was prepared for
screening as described by Kimmel A.R. ( 1987 ). Duplicate
nitrocellulose membranes were used. The membrane preparation,
probe preparation and screening protocol was from wahl <lno
SergeI' 1987 ). The probe was hybridized to the!
nitrocellulose membranes in 5x SSC, 2;< Denhart' s re.agEtnt, 200
ug/ml sonicated and denatured salmon sperm DNA, and 0.1% SOS
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at 64('C for overnight and washed 2x 15 min in Ix sse, 0.1 % SOS
at 45"C;2;.: 15 min in 0.5x SSC, 0.1% 50S at 450C. finally, the
membranes were washed in O.lx sse, 0.1%505 at 450e for 20 min.
Membranes were dried and exposed to Kodak XAR-5 film at -70oe
with a Dupont Cronex intensifying screen. About Sx 10~
recombinant phages were screened. posit.ive clones obtained
after secondClry screening were purified according to Maniatis
et al. ( 1989 ). Plaques of interested were cut out of from
the agar plate and transferred into a sterile microfuge tube
containing 500 J.1l of SM buffer and 20 ~1 of chloroform. The
tube was vortexed to release the Uni-ZAP XR phage particles
into the SM buffer and incubated 1 t.o 2 hours at room
temperature or overnight at 40e. cDNA inserts were rescued
into plasmid form in pBluescript by in vivo excision using
helper phage R408 as instructed in the Uni-zap kit. 200 J.1l of
Uni-ZAP XR phage stock ( containing:> 1x105 phage particles)
was mixed with 200 J.1l of 00600::1.0 XL-BLUE cells and 1 J.1l of
R408 helper phage ( :> lxl06 pfu/ml ) in a tube and incubated
at noc for 15 minutes. 5 ml of 2x YT media was added and the
tube was incubated for 3 hours at noc with shaking. The tube
was then heated at 7QOC for 20 minutes, and spun for 5 minutes
at 4000 g. The supernatant which contains the pBluescript
phagemid packaged as filamentous phage part; cles was saved in
cl sterile tube. A serial dilution of this supernatant was
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performed in order to plate the ~-esclled phdgemid. 200 III (If
each dilution was mixed I... ith 300 III 00,.,\,,::1.0 Xl..-Bl..UE: cel111
and incubated at 37t'C for 15 minutes. 1 Jll and 100 III each IMt:
plated on l..B/Ampicillin plates and incubated overnight dt
370C. Colonies appearing on the plate have the pBluescdpt"
double stranded phagemid with the cloned DNA insel't. 'rhe
plasmid was purified according to Maniatis t:!t al., { 1989 I
as described in Methods 2.11.
2.2.6. Sequencing Reaction
Double-stranded DNA was used for sequence analysis.
Nucleotide sequencing was done by the dideoxynucleotide Chclil1
termination method ( Sanger et al., 1977 I using the
sequenase v.2 kit ( united States Biochemicals Corporation,
Cleveland, OH. U.S.A. ) and [u-JSSjdATP ( :.-800 Ci/lllmol.
Amersham ) on double-stranded plasmid DNA templates accardi,ng
to the instructions provided. 2 III of each dNTP sequencing
reaction sample were loaded on lxTBE buffered 6'1; acrylarnide
sequencing gels. The gel was run at 55 w for 2-3 hours th(~n
was transferred onto whatman 3MM paper and dried ilt 75''C. 'I'hf~
gel was exposed to Kodak XAR-5 X-ray film ( Eastman Kodilk
Co., Rochester, NY, USA.) overnight with an intensifyiWI
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Both f;trands of t.he XFGfR-A] were sequenced with
£ynthesized oligonucleotide primers ( Oligos, Etc. ), and the
sequences were saved and analyzed using the PC gene program (
Intelliqenetics ).
2.2.7. Sequencing peR Products
Modified dideoxynucleotide chain termination method was
used to sequence PeR pl"oducts directly with the Sequenase V. 2
kit. Around BOng primer was mixed with 200-800 ng purified
peR products in 6 III of 40 mM Tris-chloride pH 7.5, 25 mM
MgCl~, 50 mM Nael, 10% Df4S0. After boiling fOl' three minutes
to denature the template, the mixture ~1dS immediat.ely cooled
dry ice to minimize template renaturation. 4).11 of
lc1b~lling mix containing 25 mM OTT, 10 IlCi [CX-J"SjdAT'P ( >800
Ci/mmol. Amersham ), and 2 units of Sequenase ( USB ) was
ddded. The resulting 10111 mixture was divided equally into
four tubes each containing 2111 of BOIlM dCTP, dGTP, dTTP,
dATP, 50 mN NaCl, 10% DMSO and 0.08 11M ddATP ( tube A ), 8 11M
ddCTP ( tube C ), 8 JlM ddGTP ( tube G ) or 8 IJM ddTTP ( tube
T ). The tubes were incubated at 37"C for 2-5 minutes, then 4
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).11 of stop buffer was added into each tube, 'I'he samples \"el'e
heated to 75° c for 3 minutes before loading onto seqllfmcing
gel.
2.2.8. RT-PCR Analysis of Gene Expression
2.2.8.1. Reverse Transcription Reaction
A standard reverse transcription protocol was used ( <\5
described by Maniatis ec ai., 1989 ), 20 ug of total RNA
prepared from different stage Xenopus embryos was I·evel·!~r:.'
transcribed into cDNA in 40 ).11 reaction volume with M-MLVW[' (
Moloney-Murine Leukemin Virus Reverse Trcln!jcriptasr~ ) by
using a oligo{dT) primer. Total RNA ft"om stage 2, stell)!? 6,
stage 8, stage 12, stage 16, stage 24, stage 30 and HL<lrJf! 41
Xenopus embryos were used ( figure lOA ).
2 • 2 .8.2. peR Methods
RT-?CR analysis was performed according to the H'r~I'CI<
methods described by Erlich ( 1989 I. ThE: PCR I'f.~actit)n \-,,)!':
done in a 50 ul volume and, in addition to the :;cllflp1f! Dr-lA,
contained 50 roM KCl, 10 mM Tris. Hel ( pH 8:.4 I, 1.5 mM r4rjCl."
100 1l9/ml gelatin, 0.25 1m of each primer, 200 ).lH or
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deoxynucleotide triphosphate { dATP, dCTP, dGTP. and dTTP l,
dnd 2.5 units of Taq polymerase. A few drops of mineral oil
was often added to seal the reaction and prevent evaporation.
The amplification was performed in a Perkin-Elmer/Cetus
Thermal Cycler ( perkin-Elmer Cetus Instruments l using the
program set to denature at 940C for lmin, anneal at 5BO<: for
50 sec, and extend at 72 1,c for 5B sec for a total of 30
cycles. These conditions were used to amplify the XFGFR!
genomic DNA fragment flanked by T305 and 5402 primers.
Modified conditions were used to perform RT-PCR reactions.
The first cycle of RT-PCR reaction was performed by o!igo(dTl-
adaptor with longer chain extension time to synthesize full
length first strand eDNA from total RNA template. Starting
from second PCR thermal cycle, genomic DNA PCR conditions
wet"e used ( Figure l4A J.
2.2.9. Synthesis of RNA Probes with T3 and T7
RNA Polymerase
Itl vitro r~'"'lnscription was used to generate RNA probes for
RNdse protection assays ( Ausubel et al., 1993 J. In v"::tro
transcription by T3 or T7 RNA polymerase was carried out in
40 roM Tris, pH 7.5, 6 roM MgCl", 2 roM spermidine, 10 mM OTT, 2
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units/~l RNase Guard ( Pharmacia l. 100 j.1g/ml BSA, 500 I.IM of
each rNTP and 100 j.19/ml of linearized plasimd DNA. The ill
vitro transcription reaction was allowed to continue for )0
minutes at room temperature. Then 0.5 unit/l.ll RNase-fl'ee
DNase was added to remove the DNA templates. The reaction
mixture was then passed through a G-50 column to Sepal"dee the
synthesized RNA probe from unreacted [Ct--'·~PIUTP. After column
purification, the in vitro transcription pI'oduets wen;!
subjected to phenol/chloroform extrelction and etlwnol
precipitation in the presence of lJ.1l of 10 mg/ml yeast tRNA.
The probe was further purified by separation throul]h d G~.
native PAGE gel. After running the gel. a short expOSll1-e of
the gel on X-ray Kodak X-ARP film was taken ( a few min ).
The gel slice containing full-length probe was excised fl"o!!l
the gel with the help of the exposed film. F'ull-lrm<]th
labelled probes were eluted by incubating the gel slice with
2 M ammonium acetate. 1% 50S. and 25 1.19/ml tRNA at 37"C f.or 2-
4 hours with shaking. Probes purified by this method gave thf;-
best results for RNase protection assays.
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2.2.10. RNase Protection Assays
RNase protection assays were performed according to the
ribonuclease protection assay protocol described by Ausubel
et al .• ( 1993 J. Full-length probes were purified by gel
electrophoresis followed by ethanol precipitation in the
presece of 10 ug yeast tRNA. 10 ug of total RNA from
different stage Xenopus embryos were hybridized at 45 uC
overnight with 10'-' cpm of the labelled antisense probe in a
solution containing 50 % formamide. 40 111M PIPES (PH 6.7 ).
400 mM NaCl. and 1 mM EDT!'.. The mixture was digested with
RNase 'i'l for 60 mins at 3)(' C followed by phenol/chloroform
extraction and ethanol precipitation. The protected products
were separated on 6 % polyacrylamide-8 M urea gel. As a
negative control. antisense probe was hybridized to 10 ~g of
tRNA. The positive control contains the 260 bp XFGFR-A2 probe
hybridized to XFGFR-A2 cRNA prepared by in vitro
transcription.
2.2.11. Large Scale Preparation of Plasmid DNA
An overnight culture of the E.coli strain containing the
required plasmid in 20 ml LB Amp ( 50 ~g/ml ampicillin} was
incubated at 37e' C with vigorous shaking ( 250 RPM). 5 ml of
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the overnight culture was added to 500 ml of fl'esh LB Amp
media. The cells were allowed to grow until the cell density
reached OD600 of 1.0. To get a high copy number of plclsmid per
bacterium, 1 ml of chloramphenicol ( 1 mg/ml in ethanol ) was
added and cells were allowed to grow for a fUl·ther 12-16
hours. Cells were harvested by centrifugation at <l000 g for
5 minutes. The plasmid was isolated from the bacteria pellet
by alkali lysis method ( Maniatis et al. 1989). The cl'llde
plasmid was further purified by cesium chloride density
gradient ultracentrifugation methods as descl'jhed by Maniatlr;
et a1., ( 1989 ). Briefly, the crude plasmid DNA was mixed
with ethidum bromide and cesium chloride and subjected to
equilibrium centrifugation at 45000 g for 16 hours. The ['olot"
was allowed to decelerate freely. The supercoi led pla51~id
band was removed from the Beckman ultracentrifugation tubl': by
puncturing the side of the tube with a 18 or 21 gauge needlf"
and withdrawing the supercoiled plasmid solution into ,)
syringe. The supercoiled plasmid solution was extracted with
water-saturated butanol to remove the ethidium bromide. 'rhe
plasmid solution then was diluted with two volumes of dll.:O und
subjected to ethanol precipitation. ThE' purity of thf~ pla~jlnid
was checked on a 1% agarose gel.
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2.2.12. Subcloning Manipulation
2.2.12.1. Restriction Endonuclease Digestion of
Plasmid DNA
Restriction endonucleases were used to manipulate plasmid.
The recognition sequences, the cleavage sites, and the
sources of the restriction endonucleases used in this
research work are given in Table 6.
The digestion temperatures, times, buffers, reaction
volume, as well as restriction enzyme and sample DNA amount
used were all according to the directions given by the
individual restriction enzyme manufacturer.
2.2.12.2. Agarose Gel Electrophoresis to
Separate DNA Fragments
TO get the desired DNA fragments after restriction
endonuclease digestion, the diges::'ed plasmid DNAs were
separated on lxTBE buffered 0.8-2% agarose gel. The gel was
stained in 1 J.lg/ml ethidium bromide for 20-30 minutes after
electrophoresis. The DNA was visualized using an ultra-violet
( UV ) trdnsluminator ( Hoef£er Scientific Instruments. San
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Francisco, CA. USA.. ) or a portable longwave UV lamp (
Fotodyne. San Francisco, CA. USA. I. The gel was photogt"dphed
with a Polaroid HP-4 cam.::ra and Kodak 22 A filter or by \Ising
a photodocumentation system ( Stratagene, La Jolla, CA. U~A.
I. The gel slice containing the target DNA fragment was cut
out of the gel, put into dialysis tubing. dnd subjected to
electroelution. After electroelution. the DNA ft"agments WCI"C
recovered and purified by phenol/chlot"ofOrln extraction dod
ethanol precipitation of the solution inside the t1i.:llynin
tubing.
2.2.12.3. Blunt End Ligation
Most restriction endonucleases give sta9get'ed cuts on DNA
molecules. There are two ways to blunt the sta9gered ends. Til
DNA polymerase can cut back or fill-in the sticky DNA ends tn
give even ends. Klenow fragment ( E.coli. DNA polymerase t
large fragment. I can fill in the 3' recessed staged ends.
Because restriction endonucleasf<s leave the 5' phonphatr:
intact, the Klenow filled in product or blunt-cut. restriction
endonuclease digestion product can be used directly in tbfl
blunt end ligation reaction without phosphorylati0n.
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The subcloning vector for blunt end ligation must be cut in
the poly linker region, blunted, and dephosphorylated on both
ends. In our case, EcoR V was used to cut KS (+) Bluescript
plasmid ( Stratagene ) to yield blunt ends and calf
intestinal alkaline phosphatase ( ClAP ) was used to remove
the 5' phosphate group,
Sample DNA fragments with blunt ends were mixed Nith
prepared vectors in the proper ratio ( Maniatis et ai., 1989
) in a final volume of 10-20 III of Ix T4 ligation buffer
containing 25% PEG 6000 ( polyethlyene glycerol), 1 mM ATP,
and 2 units of T4 ligase. The ligation naction mixture was
allowed to incubate overnight at 12-14 0 C. The ligation
mixture can then be used to transform bacteria.
2.2.12.1. Preparation of Competent Cells by the
Calcium Chloride Method
A cult.ure was grown from a single bacterial colony at 370 C
in SOD ml of LB broth with vigorous shaking until the OD600
reached 0.5-1.0 ( depending on the E.coli strain used). The
cells were chill~d by placing on ice for 30 minutes and
pelleted by centrifugation at 4000 g for 15 minutes at 40 C.
The cell pellet was resuspend in 200 ml of ice enId filter-
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sterilized 100 !lIM CaCl: and centrifuged to pellet the cells.
This wash was repeat.ed twice and t.he cells were resuspended
in a final volume of 5 ml filter sterilized 100 mH Cc1('1.~. 'The
suspension WdS stored on ice for 20·24 hours. Cold,
autoclaved. sterile glycerol was added slowly to the cell
suspension to give a final concentration of 15%. The cell
suspension was alitjuoted, frozen immediately on dry ice dod
stored at -70oc.
2.2.12. 5 ~ Transformation of Competent E. coli
XL-Blue Cells
For transformation. 50 ~l of freshly thawed competent c(~llr;
were mixed with 2~10 III of the blunt-end ligation lnb:ture in
a prechilled 1.5 ml eppendorf tube. The tube was put on ice
for 1 hour and transfered into a 42"C watet' bath for <l ]
minute heat shock. The tube \oIas then placed back on ice for: 2
minutes. 900 }ll of 370C LB media was added into the tube. 'fh(~
cells were allowed to grow at 37'Je for I hour then plated ont.o
LB/Amp plates and grown overnight at )7 f,C. only transformed
cells which carried the antibiotic gene will form colonies on
the plates.
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2.2.13. Construction and Analysis of GEX-
FGFR(VT+) and GEX-FGFR(VT-) Fusion
Proteins
2.2.13.1. Construction of the GEX-FGFR (VT+) and
GEX-FGFR(VT-) Fusion Proteins
pGEX vectors can be used in bacterial systems to express
foreign polypeptides as fusion products with glutathione S-
transferase ( GST ) ( Smith and Johnson, 1988 ). Each pGEX-KT
( Kinker-Thrombin ) vector contains an open reading frame
encoding GST, followed by unique restriction endonuclease
sites for BamHI, SmaI, and EeoRI, followed by termination
eodons in all three frames.
The pGEX-FGFR(VT+l expression vector was obtained by
subcloning the 144 bp DraI-BsaHI eDNA fragment from XFGFR-A2
into the EcoRV site of pGEX-KT by blunt-end ligation. This
subc lone was designed to leave only one threonine residue (
Thr~~'l ) in the FGFR portion. The pGEX-FGFR(VT-) expression
vector was obtained by using the same subcloning strategy;
but there was a 74 bp sequence introduced following the 138bp
DraI-BsaHI eDNA fragment from XFGFR-A3 in the pGEX vector (
Figure 6 ). This 74 bp fragment introduced two threonine
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Figure 6. Nucleotide sequence and deduced amino acid sequence
of the pGEX~FGF'R(VT"'J and pGEX~F'GFR(VT~).
Figure 6A. Nucleotide sequence of the GEX-FGFR(VT ... ) c111d GEX-
FGFR(VT~) insert. The GEX-KT vector sequence is shown in
lowercase and FGFR fragment sequence is shown in uppercclse.
GEX-FGFR (VT-) sequence ( the introduced 3' dOl·mstre,lln
sequence which can introduce two extra threonine is
underlined )
5' ccgggaat tAAAATGAAGCACCCGTCGAAGAAGTCGGACTTCAACAGCCA
ACTGGCTGGTCACAAGCTTGCCAAGAGCATCCCGCTGCGCAGACAGGTTTCAGGG
GACTCCAGCTCATCAATGAACTCTGGAGTGATATTAGTCAGACG~
TTATCGeTAAGCTTGATGTCeeCATCeTTeTC'l"rrAATTCATCGTGAC'CG/\
CTGACGACTTCAGACGatcgaat tcatcgtgactgactgacgact 3'
GEX-FGFR (VT ... 1 sequence
5' ccgggaat tAAAATGAAGCACCCGTCGAAGAAGTCGGACTTCAACfl.GCCfl.A
CTGGCTGGTCACAAGCTTGCCAAGAGCATCCCGCTGCGCAGACAGG'I',!WrCAGGG
GACTCCAGCTCATCAATGAACTCTGGAGTGATATTAGTCAGACGatcgaClttc
atcgtgactgdctgdcg<1ct3 '
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FigurE;: 6 B. Deduced amino acid sequence of the Gex-FGFR{VT.. )
and GEX-FGFR (VT-) cloning region and FGFR insertion. The GEX-
KT vector sequence is undrelined and FGFR fragment sequence
is shown in bold.
GEX-FCFR(VT-) sequence
5' pKSQI SGGGGG! ypRGSpGKKKHPSKKSDFNSQLAVHKLAKSIPLRRQV
SGDSSSSKNSGVILVRRFKLIDKLDV'l'IIFNSS 3'
GEX-FGFR(VT.. } sequence
5' pKSQI SGGGGG! VpRGSPGKMKHPSKKSDFNSQLAVHKLAKSIPLRRQV'l'V
SGDSSSSMNSGVILVRRI 3'
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residues on the FGFR; but neither of these t\"O threonine ,,,ere
contained within PKC phosphorylation site motifs ( Grdff
al., 1989 ) hence neither site should be phosphoryldted by
PKC. This pGEX-FGFR(VT-) provides a good control for the
vi ero PRC assay.
2.2.13.2. Purification of GST-FGFR(VT+) and
GST-FGFR (VT-) Fusion Polypeptides
Expressed in E. coli.
After subc10ning the chosen DNA fragment into the p(1EX-K'I'
vector in the correct reading frame, cOI~getent E.coli strdin
JM109 cells were transformed and transfor-mants were selected
on LB/Amp plates. Transformant colonies were picked a(tet
incubating these plates 12 to 15 hr at 37nC. These colollic~<
were used to prepare plasmids. The picked colonit=~{ w{~n~
sequenced to verify the constructions. The pGEX-FGPR(V']'I) .lnd
PGEX-FGfR(VT-) were expected to yield 32 ko and 35 kD flli,lon
protein respectively. The GST gene used to generate the pOE/':-
KT vector gives a 26 kD protein by itself. Large scalt= (u:;:iQn
protein purification was performed according to Smith dnd
Corcoran ( 1993 ,. Briefly, overnight cultures o[ E.coli
transformed with parental or recombinant pGEX-Y.'I' pliJ5Inid~·;
were diluted 1:10 in 800 mls of fresh medium and qrmm ~(II:
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about 1 hr before adding IPTG to 0.1 mH. After a furth~r ) hr
of gro~lth. cells were pelleted and resuspended in PBS at 1/50
of the culture volume. The cells '",ere lysed on ice by mild
sonication following the addition of 1% Triton x-IOO { 8io-
Rad I. Extracts were then subjected to centrifugation at
10,000;':9 for 5 min at 4"C to remove insoluble material. The
supernatant was mixed at room t~mperature in a 50-ml
polypropylene tube on a rotating platform with 2.5 mls 50 %
glutathione-agarose beads ( Pharmacia ). Beads were pre-
swollen in PBS. washed twice in the same buffer and stored in
PBS at 4"C as a 50 % solution ( vlv ). After a 2 min
incub"Jtion period, beads were collected by brief
centrifugation at 500xg and washed three times with 50 ml
PBS. Fusion prorein were eluted by competition with reduced
glutathione ( Boehringer Mannheim), using 2x2-min washes with
1 bed volume of 50 mM Tris. Hcl ( pH 8.0 1 containing 5 111M
reduced glutathione ( final pH 7.5, freshly prepared I.
Contamination of purified fusion proteins with E.coli
proteins, \~as reduced by including Triton X-lOO during the
incubation with glutathione-agarose and also by minimizing
the period of sonication. The yield of unstable fusion
proteins was increased by reducing the induction period to
one hOllr. Yields of fusion protein were calculated from the
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absorbance at 280 nm using the relation I A.:~" :: 0.5 mg/1111 dl1d
using bovine serum albumin as a standard. PUl' i fied fm~ioll
proteins were analyzed on SDS-l-'AGE.
2.2.13.3. PKe Assay on GST-FGFR(VT+) and GST-
FGFR (VT-) Fusion Polypeptides.
The purified fusion proteins were tested fOl- theil" aui lily
to act as substrates for PKC in vitro. The assay system (BlU,)
is designed to measure incorporation of '2P0 4 into protein,
catalyzed by purified PKC ( UBI l. The positive control fOI'
these experiments measures phosphorylation of a specifjc
substrate for PKC { Yasuda et al., 1990 1; this substrate i.l;
a synthetic peptide corresponding to a. a. 1-14 of mYfo" I i II
basic protein. As a negative control, phosphorylaUon o(
each protein/peptide was also performed in the presenc(~ o[ a
specific inhibitor of PKC activity. The inhibi.tor is i:l
pseudosubstrate peptide corresponding to a.a. 19-36 o( PKC (
House and Kemp, 1987 ).
Each assay tube contained 15 ng PKC in 20rnM Tris, pH 7.S,
20mM MgC12, ImM CaCl.~, 20uM AT?, 1011J.1 phortJOI 12-myl:"istatr~ 13-
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acetate ( Pl-1A ), 280~g/m1 phosphatidy1serin2 in o.on Triton-
z100, 5IJCi (I-l;!PATP and either 50IJM substrate peptide or 4IJM
fusion protein in a final volume of 50111. The negative
controls also contained 20llM inhibitor peptide. The enzyme
was pre-incubated with or without the inhibitor on ice for 20
min, to allow the inhibitor to bind. After addition of the
remaining components, the samples were incubated for 15 min
at 30',C and 20f.l1 aliquots were spotted onto phosphocellulose
discs. The discs were washed twice with 500 mis 0: 1%
phosphoric acid and twice with distilled water, placed in 10
mls Biodegradable Counting Sr.intillant ( Amersham ) and
counted in a Beckman Ls3801.
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Chapter 3
Results
3.1. Stage 8 Xenopus cDNA Library Construction
There is evidence that FGF' is involved in toesodenn
induction in the Xenopus embryo. Our interest Wcl$ to
investigate intracellular signal transduction during mesodenn
induction. This process begins with the binding of FGF to the
FGFR. Characterization of FGF'R genes that are expres~.ed in
early Xenopus embryos and how these FGFRs are regulated is dl1
important aspect of the stl1dy of signal transduction. So far.
all FGFRs cloned from Xenopus are from oocytes or a Xeno/I1/f;
cell line. No FGF'R has been cloned from embryos. 'rherefore,
give." the diversity of identified FGFR gene products, it WM;
important to isolate F'GFR cDNA froto the developm~ntal still]e
when mesoderm induction is believed to occur in ord~r to
obtain a more accurate or precise concept of the rnolr~cular
signalling events responsible for the first embr'yonic
differentiative event, E'or this reason, I constructf:d a cl)l~/\
library from Xenopus stage 8 blastulae.
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TwO methods that are commonly used to make eDNA libraries
dif fer in the manner that in which the eDNA is converted into
a double-stranded form. The most popular method uses the
"nick-translation" procedure develop,:::d by Gubler and Hoffman
( 198] ). This method uses the mRNA template as a primer for
second strand eDNA synthesis. Before the development of this
method most eDNA libraries were made by t:he H hairpin-
extension" method in which a hairpin structure at the 5' end
of the first strand eDNA is used as a primer for synthesis of
the second strdnd eDNA. The hairpin structure is later
removed by 51 nuclease.
Sometimes it is very difficult to reverse transcribe the 5'
end of the mRNA sequence into cDNA. This is because either
the mRNA is very large or because the mRNA has secondary
structures which prevent it from being reverse transcribed.
Therefore. it is important to select for large cONAS ( >500
bp ) before insertion into the construction vector : see eDNA
libt'aty construction chart; Fig.S ). cONA was synthesized
from poly ( A ) tail of the mRNA and COMAS were fractionated
on sephacryl 5-400 column so only cONAS >500 bp in size were
used to construct the eDNA library.
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A A-ZAPI! primary eDNA librat'Y was constnlcted with d ,;i~e
of 7XIO'; recombinants I~g of t.. phage arl1\s. The pl"imclry
amplified eDNA library had a titer of 5xlOIl p.f.u/ml ( plaqu(:'
forming units/ml ). Forty plaques from the prillklt"Y <'lmplifjed
eDNA library were picked at random and checked by peR with T3
and T7 primers for the proportion containing inset"ts dnd the
range of insertion size. Thirty-eight colonies had imlez't ionl~
with an average size of 800 bp. The smallest one held 200 bp
insertion and the largeset has 5 kb insertion"
estimate then that at least 95% of the t'ecombinantG had "DNA
inserts. This result met the eDNA librdry construction
criteria ( over 90 1; of the recombinants have to have eDNA
inserts l The construction of this A-ZAP!I eDNA libldl"Y (n)lII
stage 8 Xenopus mRNAs was a successful one, considednq 5:<10"
recombinant bacteriophages is a mammalian eDNA libt"ot"y of.
reasonable size. Only primary amplified eDNA librarief;
used for the screening process to isolate XFGF t"eceptrJ!" cDNA
clones,
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3.2. Isolation and Sequence Analysis of the
Full Length XFGFR-A3 eDNA Clone
Approximately twenty positive plaques were isoJ "lted by low
stringency screening of the primary amplified stage B Xenopus
cDNA libt"ary with a 400 bp probe consisting of part of the
tyrosine kinase dOmain of xenopus flg. The 400 bp sequence
had been cloned from peR amplification of Xenopus stage 17
cDNA using primers designed from the chicken fig sequence. A
phage density of 5000 p. f.u per 150 mm NZY plate was used in
the first screening process. Each posit:ve from this scree:!
was a mixture of severa': overlapping phage plaques. All
twenty positives were subjected to PCR amplification with
FGF'R specific primers. only one positive named 8A-l, gave a
positive PCR result. This positive was used for a second
plating with lower phage density so that single plaque could
be picked from the plate. By combining TJ or T7 primers with
FGF'RI specific primers XFGFRS', XFGFRJ', or Sequence 4
TClble 4 l, this particular eDNA clone was identified as a
XFGFRI eDNA clone according to peR results ( Data not shown
). The predicted full-length XFGFRI eDNA was 3.5-4 Kb based
on previously cloned XFGFRs. This A phage clone was then
r"escued into plasmid form with the help of the R408 phage.
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Large scale plasmid preparation and restriction endollucledse
analysis were carried out. This positive clone \~as sequence,1
using the dideoxynucleotide termination method \~ith synthetic
oligonucleotides. Seven batches of oligonucleotides \'Hne
synthesized in order to get the complete sequences ft'om both
strands ( Table 4 ). The sequencing ddta was storNl <llld
analyzed with the PCGENE program ( Intelligenetics ). Thil.;
newly identified XFGFRI variant was desigodted XFGFR-l\3 to
distinguish it from the two previously identified Xt::llOptW
FGFRs XFGFR-.~l and XFGFR-A2 ( Friesel and Dawid, 1991 ).
XFGFR-A3 eDNA is 3863 bp in length ( Figure 7 ). It. 1M!; ~l 11l~
bp 5' and 1250 bp 3' non-coding sequence. Its open l'eddjn'l
frame (from nucleotides 183 to 2613 ) is 2430 bp in length.
The open reading frame of XFGFR-A3 is predicted to encorlf) ,)
protein containing 810 amino acids ( l'igure 7 ). 'l'h(1
predicted KFGFR-A3 protein sequence has virtually th0 Sdlll(:
structure as previously reported FGFRs. It consist!:: of d ~l
aa signal peptide, a extracellular ligand hinding domain (
351 aa ) with three Ig-like domains and an acidic box hetW!?I1tl
first and second Ig domain, a transmembrane dOlnClin of 21 dd
and a cytoplasmic domain of 417 aa. The cytoplasmi(; dOln<lin
includes a 74 residue juxtamembrane domain Clnd a tYfO:,;llll~
kinase domain split t:ry a 14 aa insertion. The 1250 bp 3' non-
coding region contains a potential cytoplasmic
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Figure 7. Nucleotide sequence and deduced amino acid sequence
of the XFGFRI-A3 eDNA clone. The presumed signa! peptide
sequence, transmembrane region, and the potential cytoplasmic
polyadenylation element and the hexanucleotide
po!yadenylation signa! AATAAA in the 3'end untrans!ated
region are underlined.
121 C1'TC'J'CT<'GTGCCTGACACTGGAOOTCTCATCGATTTCGQCTGTGTGCACTAGCCAAC'IT
GGGATC;TTCTCCGGAAGGTCCCTCCTCCTCTGGGGTGTCCTGCTrGGAGCTGCTTTATCA
MESGBSIllWGYflGAAIS
G~CCCGGCCCCC'M'CCACCCTCCCCGACCAAGTCGCCCCTAAAACCAAAACOGAAGTG
'L.....l!:.RPPSTLPDQVAPKTKTEV
GAGCCGTA'M'CTGCTCAGCCAGGAGACAGGATAAC'M'TGCAGTGCAGGCTACGAGAAGAT
EPYSAQPGDRITLQCRl..RED
G'M'CAGAGCATCAACTGGCTGAAAAATGGACTTCAGC'M'TCGGAGACTMCCGCACGCGC
VOSINWVKNGVQl..SETNRTR
ATAACAGGGGAGGAGATCCAAAT'M'CCAACGCAGGGCCGGAGGACAATGGGGTGTATGCC
I TGE EI QISNAG PEDNGVY A
TG'TGTTACTAACGGGCCTTCTCGAACATATACAGTA'M'A'M'CTCCGTTAATCTATCAGAT
CVTNGPSRTYTVLFSV NVS D
GCACTGCC'I'T<"OOCCCAGCACGATGATGAAGATCATGACMTTCATCCTC7GAGCAGAAA
AI.. PS AEDDDEDDDNSS SEEK
CC1'GCACAAAACTCC AAACCCAACCCTCCAC'M'TGGTCACATCCAGMAAAATGGAGMG
,1..1'. ENSK PNRPLWSll PE KMEK
AAGCTTCATGCAGTGCCAGCA""MAAACTCT1.AAAT'M'AGCTGTCCAGCAAATGGAACT
K LHAVPAAKT'IK PRCP ANG T
721 CCAACGCCAACAC1'TCGC'l'GGCTGMGMTGGCAGGGCGTTCCAACAAGATCAGCGCA'M'
PT PTLRWLKNGRAFQQ DOR I
781 CCTGGATATAAGGTCCGGTCTCAAACATGGAGTCTTATTATGGA'I'T('CG'M'GTCCCATCT
GCYKVkSQTWSl.. IMDS 'IV PS
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GATAAAGGAAATTACACC'KlTA1'1'O'I'GGAGAACA,\OTAn::GTGCTA'T'CAACTA(',\('NfM:
D K G N Y T C I V E N K \' G A I N II '1' \'
901 CAGTT..-:;ATGT'I'GT'I'GAGCGTICCCCACACCGCCCAA'T'CC'1'ACAAGCCGGTCTCCCAGCG
Q L D V V I': R S P H R P I I.. <) A G I.. P ,\
961 AATACAAGCGTTACTGTGGGAACC AC AGCCGAATTTTCC1\lC AAAG'l'VTACAGCGACC"CL'
NTSVTVGTTAEF SCKVY SO f'
CAGCCTCACATCCAATGGCTCAGCCACAT'l'CAAATTAACGGCAGCAGAG'I\.l(lCCTC"GGNI'
Q P II I Q W L R H I I': I N G ,<: R V A :; [l
GGCT'l'CCCGTATGTGGAGATCCTCAAGACTGCAGGACTCMCACC1'CGGAC rw..--':'ATA'l\:;
G F P '{ V ElL K '1' A G V N 'r S (l K D ~l
1141 GAGG'l"TCTCCACCTGAGAAATG'M'ACT'I"'MUAGGA't'GC'TCGCCACTATACCTGC'!'1'1.::GCC
EV LH LRNVT F'I':OAC<)YTCLA
GCTAACTCCA'M'GGGATCTCTCATCATTCTGCATGGTTGACCGTTC'I'1'AAAGT1'lJAGGAt
ANS IG I S HHSAW LTVLK VI': [l
AATAAACCTGCGCTTCTGGCCTCC'::C7i'TACAACTGGAM'!'1'ATC ATCTAC.1'GCAOC,(.:tX:
NKPALLA,;PLQLEIIIYCTC
GC't'GC'M"M'GTGTCCGCAATGGTGGTCACCllTCATTATC'ITTAAAATC:AlIG('lICC('~::·I'C~:
AAEyStlMyVTT I IEKMKHl'f;
1381 AAGAAGTCGGAC'l"TC AACAGCCAACTGGCTGTGC AC AAGCTTGCCAAGlIGC'!I1'('CCGC1n
KKSDFNSQLAVH KLAKS I P L
CGCAGACAGGT'I'TCAGGGGACTCCAGCTCATCAA't'GAACTCTCGAG'I'Gl\'rATTAG'I'CAC:/I
RRQVSGDSS SSMNSGVI LV fj
1501 CGCCTTTCT'1'CCAGTGGGACTCCCATGTTGTCTGGACTATCGG/,ATA'J'GAGC'I"rCCAGAI,
R L S SSG '1' P I" L S G L S E' Y ELf' E
1561 GATCCACGATGGGAAG'I'GGCAAGGGACAGACTGATCCT't'GGGAAACCTC'i'CGGAGAM:C:C
D P R W E V A R 0 R L I L G K P L G l' (:
TGCTT'rGGGCAAGTAGTCATGGCGGAGGCTATTGOCC'I"CGACAAGOAGAI,GC(1'/,lICAAlI
CFGQVVliAEAIGLDKEY.PlIK
GTAACAAAAGTTGCTGTGAAGA'I'G'M'OAAGTC'I'GATGCGAGTGAAAAGGA.CC1'f;'f'(;GGl,T
V T K V A V K '" L K S D A S E: K tl L ~; D
1741 CTCATTTCCGAGATGGAAA'fGATGAAAATCATTGGAAAACA.CAAAAlITA1'I,NrTAN/""I'TI,
LIS E 11 E 11 '" K I~ r G r. II r. H I I 1I L
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C'I'TCCTGCC1'GCACCCAAGATGGTCCACTCTATGTAA'M'GTCGAATACACTTCCAAGGGG
LGACTODGPLYVIVEYTSKG
AATCTGAGAGAG'J'AC'M'ACGQGCCAGGCGCCCGCCGGCGATGGAGTACTGCTACAACCCT
NLR EYLR ARR PPAM £YC YN P
ACCTGTGTCCCCGATCAGCTGC'ITI'CCTTCAAAGATC'I'GGTGTCATCTGCTIACCAGGTG
TCVPDQL LSFKOLVSCAYQV
GCACC'l'GGCA'l'CGACTACCTAGCCTCTAAAAAGTCCATCCACAGAGACCTGGCTOCAAGG
ARGHDYLASKKCIHRDLAAR
2041 AATG1"J'T'J'AGTAACAGAOOACAACATMTGNlCATTGCCG1\'M'TCGCGTIAGCCCGTOAC
N V L V TED N I M K I A 0 F ,. L A R 0
ATCCATCACA'ITGACTA'M'ATMGAAAACGACAAATGGCCGGCTGCCTGTAAAA'fCGATG
IHHIDYYKKTTNGRLPVKWM
CCCCCAGAAGCACTGTT1'GACCGGATTTACACTCATCAGAGCGATGTG'I'GGTCG'I"M'GGC
AP EALFD RI YTHQS OVW SFG
GTGCTGCTGTGGGAGAT'M'TCACACTrGGTGGCTCCCCATATCCGGGTGTCCCCA'I'GGAA
VLLWEIFTLGCSPYPCVPME:
GAACTCTTTAAGTIACTCAAGGAAGGGCACAOOATGGATAAACCCACTAACTGCACCAAT
E: L F K L L K E: G H R M 0 K P T I. C T N
CAGT'T'GTA'J'A'J'GA1'GATGAAGGACTG'M'GGCATGCCATGCCCTCTCAAAGACCAACATTC
ELYMMMK OCWHAMPSQR PTF
AATCAGCTGOT'I'GAGGATC'I'TCACCGAATTCT'l'GCTC'I'CAGTTCCAATCAGGAATA'I'C'M'
NQ LVE:DL OR I LALSSNQEY L
GATCTCTCCA'roCCAGTGAATC AGTAT'I'CTCCATG1'TTCCCAGACAC'I'CGAAG'I'TCGACG
OLSM PVNQYS PC FPOTR SST
TGTTCTTCAOGCGAGGACTCTCTGTTCTCTCA'l'GACCCCCTCCCCGATCAGCCCTGCC'M'
CSSGEOSVFSHOPLPDEPCL
2 sal CCCAAATACTCCAATCGTGGAC'M'AAAAAACGC'l'GACCTTGGGGG'M'C'M'T'I'CGGCTTCT
PI{YSNGGLKKR
2641 TCTCCAT1.. ~~T'l"CCATTTAAAGAACATTI'GTTM'GAAGCATTCCAGAAATCCCACAAGT'J'
210 1 CCTCAGAACCArocTACAATTCCACTCCTACATCTICAGCC'ITATTCCTTTACACA'l'GCA
~161 CTTTGTAGGAGGTAC'M"M"M"I'GG'M'GAGGATGGAACCAGCAATATTC'CTAATCTTGACC
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2881 ACATGGCAATATCATGGGAACTTATCGAGTAGAA>\CT1"TGCCAACTC'T"l"'M'AA'T',\'l"TCC'\,
2941 CAATT'M'A'l'CACA'I'T'M'A'l'TTTCC'l'CACCTCATCTATATA.TCAAAACC'l'G,\CCC...m:;'l'('C
C'I'TGTAGCTAGG'ITACAC'I'T'rCTCC'l"fGCTCTGACCAAGCCCATrc'l'"'rC1'C'CA1't\'rrCCA
3181 ATCCAAGACCTGC',C'M'CCTTCAAC'TCAATTATCAACCCAGACC"rcA'rrATAAL1CTAC't\'!'
) 421 TCCAACGTTTTTACTAGAGGT'M'GACTGAAGCCGTGTGTT'J'('AG'T'GAAt\lXC'C'C,\'!W!'AA
3601 GCTTTCCTTTTGTATATACCTAAAAAATCTATAAATATCAATTATATt\'I""I'ACAR;'I't.~J·I'
3 6 61 T'M'AAGAAAAAAJI,AAAAAC'T'TACAAAATATATACCACGTCAGT/\,G'rAAAGTGGc-rGGT/\,G
TTCTCAATCCCTATAAAAAGAAATCTTATAT'M'TGCTA'I'G'!'T'M'CAG'J'T't'G'I'A.1.,..rl"t"l·r
3841 TAACCTAAAAAAAAAAAAAAAAA
79
Figure 8. Protein Sequence Alignment of XFGFR-A3 with XFGFR-
Al and XFGFR·A2. The asterisk stands for conserved regions,
dot for conservative changes and a space indicates non-
consservati',:e changes. Dished line stands for amino acid
deletion.
XF'CFR-Al MFSGRSLLLWGVLLCAALSVARPP5TLPDEVAPKTKTEVEPV5ARPGDTV
XF'CFR-A3 I~FSGRSLLLWGVLLGAALSVARPPSTLPDQVAPKTKTEVEP'i5AQPGDRI
XF'CFR-A2 I~FSCMSLLLWGVLLCAALSVARPPSTLPDE-- - -- -- - --- -- - - ----
XFGFR-Al
XFGPR-i\3
XFGPR-1\2
XI'X;FR-Al
XFGFR-A3
XFGF'R-A2
'l'LQVRLREDVQSlSWVKNGVQLLETNRTRITGEEIQISNAGPEDNGLYJr..C
TLQCRLREDVQSINWVKNGVQLSETNRTRITGEEIQISNJr..GPEDNGVYJr..C
VTIGPSGTVTVLFSIN\lSDJr..QPSJr..EDDDDDDONSSSEEKASENSKPNRPF
VTNGPSRTYTVLF5VNVSDJr..LP5AEDDDEDDON5S5EEKAAENSKPNRPL
- - - - - - - - - - ----- -- -DJr..LPSAEDDDEDDON5SSEEKAAENSKPNRPL
XFGPR-Al WSHPEKMEKKLHAVPAAKTVKFRCPANGTP5PJr..LRWLKNGKEFRPDQRIG
XFGPR-A3 WSHPEKMEKKLHAVPMK'IVKFRCPANG~PTPTLRWl.KNGRAFQQDQRIG
XI'X;FR-A2 WSHPEKMEKKLH,lWPMKTlJKFRCPANGTPTPTLRWLKNGRAFQQDQRIG
.............................................
.. ....
XFGFR-Al GYKVRSQTWSLIHDSVVPSDKGmTCIVENKYGTLNHTVQLDWERSPHR
XFGFR-A3 GYKVRSQTWSLIHDSWPSDKGNYTCIVE:NKYGAlNHTYQLDWERSPHR
XFGFR-A2 GYKVRSQTWSLIHDSVVPSDKGNYTCIVE:NKYGAlNHTVQLDWERSPHR
XFGFR-Al
XFGFR-A)
XFOFR-A2
XPGFR-Al
XFGFR-A3
XFGFR-Jr..2
PILQAGLPJr..NT:3VTVGSTAEFSCKVYSDPQPHIQWLRHIEINGSRVASDG
PILQAGLPANTSVTVGTTAEPSCKVYSDPQPHIQWLRHIEINGSRVASDG
PILQAGLPJr..NTSVTVGTTAEFSCKVYSDPQPHIQWLRHIEINGSRVJr..SDG
FPVVEILKTAGVtrTSDKDMEVLHLRNVTFEDAGQVTCLAANSIGISHHSA
FPYVEILKTAGVNTSDKDMEVLHLRNVTFEDJr..GQYTCLAANSIGlSHHSA
FPVVEILKTAGVtrTSDKDMEVLHLRNVTFEDAGQVTCLAANSIGlSHHSA
XFCFR-A: WLTVLEVEDDKPALLA5PLQLEIIIYCTGAAFVSAMlJVTIIlFKMKHPSK
XFGPR-A3 WLTVLKVEDNKPALLASPL(>LEIIIYCTOAAFVSAMVVTIIIFKMKHPSK
XFGFR-A2 I>:LTVLKVEDNKPALLASPLQLEIIIYCTGAAFVSAMVVTlIIFKMKHPSK
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XFGFR-1I1 KSDFNSQLAVHKWlKSIPLRRQV1VSGDSNSSHHSGVJLVRPSRLSSSGT
XF'CFR-A3 KSDFNSQWlVHKLAKSIPLRRQV~-SGDSSSSHNSGVlLVR-~RLSSSG'r
XFCFR-1I2 KSDFNSOWlVHKLAKSIPLRRQV1VSGD$SSSNNS(:VILVR-~RLSSSG1'
XFGFR-Al PMLSGVSEYELPEDPRWEVARDRLILGKPLGEGCf\>QVVl'IAE,\IGI..DKEK
XFGFR-1I3 PMLSGLSE:YELPEDPRWEVARDRLILCKPLGECCF'CQVVl'IAE:AIGLDKEK
XFGFR-i\2 PMLSGLSEYELPEDPRWEVARDRLILCKPLGEGCFGQVVMAEAIGLDi,EK
XFGFR-i\2 PNRVTKVALKMLKSDANE:KDLSDLISEHEMMKMIGKIlKNIINLLGAC1\l1l
XFGFR- A3 PNKVT!<VAVKMLKSDASEKDLSDL I SEMEMt·1KMIGKHKNI INLLGACTQO
XFGFR-1I2 PNKVTKVAVKMLKSDASE:KDLSDLISEM£NMKMIGKIlKNIINLLGAC1'QD
XFGFR-1I1 GPLYVIVEYASKGNLREYLRARRPPCMEYCYNPMCAPDQLLSFKDLVSCA
XFGFR-A3 GPLYVIVEYTSKGNLREYLRARRPPAMEYCYNPTCVPDQLLSFKDLV!KA
XFGFR-A2 GPLYVIVEYTSKGNLREYLRARRPPAl1EYCYN?'I'CVPOOLLSFKDLVSCA
XFGFR-A2 YQVARGMEYLASKKC IHRDLAARNVLVTEDtNMK 1ADFGLARDIllllI DYY
XFGFR-113 YQVARG~IDYLASKKC I HRDLAARNVLVTEDNIMK I A.OFALA.RDI 1m I DYV
XFGFR - 112 YQVARGMDYLASKKC I HtlDLAARNVLVTEDN IMK I ADFRLARDI IIH IDYY
•• '* ..
. .
XFGFR-1I1 KK'M'NGRLPVKWMAPEALFDRJi"fHQSDVWSFGVLLWEIF1'LGGSPYPGV
XFGFR-AJ KKITNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIPTLGGSPYPGV
XFGFR-A2 KKITNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIPTLGGSPYPGV
XFGFR-Al PMEELFKLLKEGHRMDKPTNCTNDVYr-l11:-lKDCWHAMPSQRPTFN{>LVEDL
XFGFR-A3 PMEELFKLLKEGIlRMDKPTNC'l'NELYl-l11~KDCWHAMPSQRPTFNQLVEDl,
XFGFR-A2 PMEELFKLLKEGHRMDKPTNCTNDVYMHI~KDCWHAMP5QRPTFlJQLVElll,
....... ~ .
XFGFR-Al DRILIILSSNQEVLOLSMPVlJQYSPCFPlYI'RSST<:SSGEDSVFr.~IfDPLPOI;;
XFGFR-1I3 DRILIILSSNQEYLDLSMPVtlQYSPCFPlYI'RSS1'CSSGEOOVFSHDPLPm;
XFGFR-A2 DRILIILSSNQE:'l'LDLSMPVNQYSPCFPDTRSSTCS.scElY.;VF~lmPLP[)E
..... ~ .
XFGFR-Al PCLPK'iSNGGLKKR 814
XFGFR-1I3 PCLPKYSNGGLKKR 810
XFCFR-1I2 PCLPK'iSNGGLKKR 724
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Figure 9. Nucleotide sequence alignment of XFGFR~A3 \~itll
XFGFR-A2. The charactp.r to show thclt t\~O aligned residlln,
identical is 'I'. Total number of bases in XFGFRA2: 2753.
Total number of bases in XFGFRA3: 3863.
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FirJure 10. RT-PCR clnalysis of XFGFR-AJ expression with OD-1
and 5402 oligonucleotide primers.
Pigure lOA. Schematic dia.gram showing RT-PCR technique.
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Figure lOB. Schematic diagram showing the lOc<ltions of PeR
primer T305, co-I, Px-2, and S402 on XFGFR-l. Proue used fot"
screening the library is also shown. The restt'iction ell~ym('
sites, and VaL4:l-Thr4:4 digeptide location at'e inrlicdt:ed by
arrows.
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F'iqure lOCo cONAs from six different stage Xenopus embryos,
Jlong with XFGFR-A3 plasmid, were peR amplified with 00-1 and
5402 primers ( to recognize the XFGFRvA3 sequence only ) or
with TJ05 and 5402 primers ( to recognize all XFGFR-l/ flg
variants). T305 and 5402 primers are used as a PCR
amplification control. PeR W.1S performed as described in the
Haterials and Methods section. Total RNA '",as isolated from
different stage Xenopus embryos and cONA was synthesized
using an oligo { dT } primer. Following 32 cycles of PeR
amplification, 10 1 of each PeR product was run on a 2 %
agarose gel in lxTBE buffer. The results indicated that XFGFR-
A] was expressed in all stages of Xenopus embryos. Lane 1, ],
5,7, 9 and 11 are RT-PCR products from stage 2,6,8, 24, ]0
and 41 embryos with T]05 and 5402 as primers. Lane 2, 4, 6,
8, 10 clOd 12 are peR l.'coducts from stage 2, 6, 8, 24, 30 and
H embryos with 00-1 and 5402 as prirl"ars. Lane 13 is RT-PCR
product from XFGFR-A] plasmid with 00-1 and 5402 as primers.
Lane 14 is RT-PCR product from XFGFR-A] plasmid with T]05 and
giJ02 as primers. Lane 15 is 1 Kb ladder ONA size markers.
1 2 3 4 5 G 7 8 9 10 11 12 131415
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Table 5. Oligonucleotide primers used in the s0quellcing ,)]1,\
RT-PCR experiments.
sequences ( 5' to )' I
T3-4
T7-'
DO-1
T3-3
53-3
T3-5
S3-5
53-4
54-4
T7-3
54-3
53-2
54-2
54-5
T7-5
PX-1
PX-2
T3-6
T7-6
T3
T7
T3-2
T7-2
PO-1
ACA AGC CGG TCT CCC AGC GAA T
GTC TTA GAT GGT AGC CTC GAG T
GCG (' ""0 ACA om 'M'C AGG e.G
G..:T 'T'CA TCC Aor OCC AOC
CCT AAT G'M' O"'C CTC CAG
GGG CTC CTT 'M'G TGT CCG CAA T
CAC TGA AG(C)C om TGT'M'C AGT G
CTC cn GTA OCT AGG TIl\. GAC T
G'IT GAC TeC TGC AGT CT'!' GAG 0
GOT TGC ATA ATO AGC ACA
TTG 'I'GC ACA GeC l\OT '!'GO
CTC GM OTT CGA COT G
OCC ATG ACT ACT TGC C
TGC CAT TeT 'J'CA OCC AGC GAA G
TCC T1'C TO;" GGA ACT TG1' GOC A
COC TGC GCA OAC AGG TAA CAG T
CAC TGO MG AAA GGC GCG MG 0
GCT AT'!' GGC C'l'G GAC AAG GI\G A
ATe GO. TGC CM CAG TeC TTC A
GC'I' CGA AA':' TAA cec TeA CTA AAG
GeT ACC TAA TAC GAC TeA CTA TAG co
AOA GCA 'I'CA ACT oor G
CTA CTG ACC '!'GO TAT ...
GAG AAT TeG TCG ACA TCG A'M' T'M' 'l'TT
TIT TIT TT
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'J'D-974
lOI6-:HlJ7
D95-\4 r,.,
(;(,)·6110
2nOA·~A2r,
DI9-IHIl
'444-1ol(,~,
1111l-l\:I'l
Jl (II . I I 2:~
33l'.>·J:'S:l
1401-I'ltA
16211-lr,4]
';)1-754
2690-2710
N/A
14'14-1<;13
!tl2(,-164A
2357-2i7!1
NfA
11//\
)(;S-lliO
1fl'IO-3711'j
tU/\
polyad(mylation element and the hexanucletide polyadenylation
signal ( AAUAAA ).
A unique feature of the XFGFR-A] clone is the Val4:D-'I'hr4~4
dipeptide deletion caused by 6 nt deletion located in the
juxtamembrane region of XFGFR-A3, which could result: in the
loss of a putative serine/threonine phosphorylation site. A
simi lar variant of the human flg gene has been identified (
Hall et cli., 1991 1. This is the first time such a variant has
been described in Xenopus. XFGFR-A3 shows more homology at
the amino acid level to XFGFR-A2 than to XFGFR-Al { Fig 8 ).
XFGFR-A] and XFGFR-A2 have identical 5' non-coding sequence
which indicates they are likely the same gene products (
Figur« 9 ). Therefore XFGFR-A3 is a variant of XFGFR-A2. The
main differences between XFGF'R-A2 and XFGFR-A] are: 1 ) XFGFR-
A] is a three Ig-like domain form and XFGFR-A2 is a two 19-
like domain form. 2) XF'GF'R-A] has a 6 nt deletion at
juxtamembrane region which can cause Val4:3-Thr 4:)4 dipeptide
deletion. In addition, there are five single amino acid
di fferences between A2 and A]. The XFGFR-A] nucleotide
sequence and deduced amino acid sequence are described in
Figure 7.
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3.3. RT-PCR Analysis of XFGFR-A3 and XFGFR-A2
Expression during Xenopus Embryonic
Development
The 00-1 primer ( Figure lOB, 'l'(lble 5 ) WdS dp'~,jlJll<'d
according to Va14~J-Thr·I.~.1 dipeptid.e delet.ed l'('~Jjlln of ;{1'I.;I<'1\
A3. Px-1 was designed accordina to the t'..'IlIle retJi"ll ill X\-'1:I'H
A2 ( FigUl'C lOs). px-2. '1'305 and 5402 pl"i.III€'n~ <11"<-' 10".11 I'd
outside this region and recognize both XFGFR-A) .mtl XFGFH-fl:!.
00-1 and 8402 primers wel"e used in tbe PCR cliliplificcltinil 1"<,
specifically amplify FGfR-A) cDNA wbile rx-l .11Kl P:·:·2 prillll:I'~:
specifically C1mplify the same region on I'GI"R--A~. '1'30':' ,11111
5402 primers were 'Jsed in each expel-iment tlJ (:P~;\II'I: tlldl 1.11':
RT-cDNA used as a template contains the l"(~(Jioll or i IIte("(~:-;I.;
they amplify fragments of 326 bp and 330 bp III f.;i~(: ['rOIlI
XFGFR-A2 and XFGfR-A3, respectively, and cov(~r tIle 1"(:'JiUll
that the primer pairs oD-1 and 5402 or Px-l and 1"'>:-2 umplify.
The RT-PCR results shown on Fig.10C and 13 d(~mon~_;tr-,)t,-,rJ tll<)L
both XFGFR-A3 and XFGFR-A2 mRNA are prr:osent .:II' d II :;t<l'Jr:f~ 01
Xenopus development. Although RT-PCR i~'l a v(~ry f;;en:Jiti.v(:
method and has many advantages over Northern un'.I lyre: i~: j n
terms of detecting gene e>:pression, it is very di f[jclllt tn
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quantitate, even with an internal PCR control ( Siebert and
Larrick, 1992 ) Therefore, to obtain information about the
ratio of each XfGFR1 isoform in the whcle XFGFR1 mRNA
population and a detailed expression pattern of each, RNase
prote,-:tion assays were performed.
3.4. Probe Construction for RNase Protection
The RNase protection probe was obtained by subcloning a 162
bp BstEII-BsaHI cDNA fragment covering the VT dipeptide
deletion region of XFGFR-JI,2 into the EcoRV site of
pBluescript KS (+) ( Stratagene. La Jolla, CA , USA ) by blunt-
enu ligation. The location of this 162 bp XFGFR-A2 fragment
in XfGFR-A2 is shown in Figure 11; it covers nucleotides 1046
to 1212 of XFGFR-A2. Restriction enzymes used in this
construction and other subcloning manipulations are listed in
Table 6.
Transfurmation of competent E.coli XL-Blue cell was
performed as described in Methods ( 2.12. ). The orientation
of the insert was checked by PCR with T7 and 54-3 primer
pairs. Transfarmants that gave fUll-length inserts were
subjected to large scale plasmid preparation, as described in
methods { 2.12. l. The purified 162 bp XFGFR-A2 plasmids were
verified by sequencing.
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Table 6. Restriction endonucleases used and their recognition
sites.
BamHI
BsaHI
BstEIl
EcoRI
EeoRV
HindIII
SpeI
Not!
XhoI
G/GA'I'CC
GR/CGYC
G/GTNACC
G/AATTC
GA.T/ATe
A/AGCT'r
AlC'I'AG1'
GC/GGCCGC
C/1'CGAG
"I" indicates the point of cleavage within <I t-ecO<Jnit,ion
sequence.
R= A or G N:A or C or G 01' T
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Figure 11. Diagrammatic representation of probes used in the
RNase protection assays. The locations for the RNase
protection probe with respect to the juxtamembrane region and
the expected protection fragments for both the XFGFRI-A3 and
XFGFR-A2 tr.;J.nscripts are shown. Arrows indicate the locations
of the restriction enzyme sites and the location of Val4~3­
Thr~~~ dipeptide in the juxtamembrane region. The probe is a
162-nt BStEII/BsaHI digested XFGFRI-A2 eDNA subclone.
Transmembrane region
•BstE11 •V1 •BsaHI
Tyrosine kinase domain
I I----C:::J-
(162 nt) t( )r XfGFR-A2
('07nt.49nt)~~XfGFR-A3
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3.5. RNase Protection Assay to Examine XFGFR-A3
Expression During Xenopus Embryonic
Development
The probe used for the RNase protection experiments WdB
prepared by subcloning the correspondinQ XfGfR-A2 plasmid
region into KS {., plasmid as mentioned above ( 3.5.'. '1'0
generate a XFGfR-A2 probe·' for Rflase protection, the plasmid
was linearized by XhoI ( locilted in the polylinket- region).
A [a-3~pluTP labelled antisense probe was generated by ill
vitro transcription from the T? promoter This probe is 246
bases and protects a 162 bp fragment in F'GFR-A.2 ilnd
fragments of 107 bp and 49 bp in PGFR-A) ( Figure 11 1.
TO serve as a positive control for the protect ion as~ay.
plasmids containing the full length XfGFR-AJ and XfGPR-A7.
CDNAS were linearized at KpnI site and XhoI site.
respectively, and subjected to in vitro transcription with T3
RNA polymerase. RNase protection assays of XFGFR-A2 and XFGf'R-
1\3 cRN1\ enabled me to verify that the protected fragment:;
were of predicted size and that the digestion waG complete.
A KS(.) plasmid containing 420 bp insert of OOC "Jar;
digested with XhoI and transcribed by T7 RNA polymerasf~ to
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oroduce an antisense RN.r;, probe ( The 420 bp Xenopus OOC (
Ornithine decarboxylase) plasmid is a gift from Dr. J. M.
Slack to Dr. G. D. Paterno. ). This probe is 420 bases and
can protect ODC transcripts to yield a fragment of 327 bp.
This OOC probe served as a RNA loading control probe to
detect the uniformly expressed ODC-l transcripts in all
different stages of Xenopus embryos.
using RNas'O! protection assays, I analyzed XFGFR-1'.3 and
XFGFR-A2 expression quantitatively throughout Xenopus
development. Consistent with the RT-PCR results, both XFGFR-
1'.3 and XFGFR-A2 mRNA were present throughout Xenopus
develooment. The level of expression for each form of the
XfGFR was constant through the stages examined. The results
also showed that XFGFR-A3 was expressed at a much lower level
than XFGFR-A2 ( Figure 12 I. There were two protected bands
for XFGFR-A2. It could be caused by t.he secondary structure
formed between XFGFR-A2 mRNA and antisense probe at the 3'
end of the duplex; Because this protection pattern was also
present in the XFGFR-1'.2 mRN1'. control samples. By scanning and
comparing the 107 and 162 bp bands on autograph ( GelScan XL
). I determined that the mRNA copy number of XFGFR-1'.3 was 5.5
% of the XFGFR-A.2.
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Figure 12. RNase protection assay of XFGFR-A] expression
during Xenopus embryonic development. The assay was performed
as described in Materials and Methods. 10 ~g total RNA from
different stage embryos were hyb:ridized with [y-.I~pJ dATP
labelled XFGFR-A2 probes ( 5XlO~ cpm ). The ODC-1 probe (
5Xl03 cpm ) was included with each RNase protection sample to
monitor RNA loading equivalency. The autoradiograph was
exposed to Kodak XAR-5 film for 48 hours with intensifying
screen. Arrows indicate the fr<tgment size of corresponding
DNA band. Lane l:in vitro transcribed cRNA strand from XFGfR·
A2 protected by the XFGFR-A2 probe. Lane 2: in vitro
transcribed cRNA strand from XFGFR-A] RNA protected by the
XFGFR-A2 probe. Lane ]. 4, 5, 6. 7. 8, 9 , 10, and 11 are
total RNAs from stage 2, 6, S, 10, 16, 24, ]0, ]6, and 42
embryos respectively and protected by the XFGFR-A2 and ODC
probe.
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3 .6. Genomic DNA Approach to Analyze the
Nucleotide Sequences of the VT Dipeptide
Deletion Region of XFGFR-A3
TO investigate the cause of the VT dipeptide deletion in
XFGFR-A3, sequence analysis of genomic DNA was perfonned.
Pt:R of genomic DNA. is a fast and efficient way to obtain
sequence information of the genomic DNA fl<1nking the VI'
deleted region. A Xenopus genomic library ( Stratagene, La
Jolla. USA ) was used as a substrate in the peR
amplification. The principle of this genomic peR method in
shown in Figure 1411.. Two primers T)05 and 5402 I Table 5 )
were used to amplify the XFGFRI genomic DNA corresponding to
the region. A 1.2 Kb band is amplified from the genomic DNA
while a 300 bp band was amplified from the eDNA. library. The
amplified Xf'GFRl genomic DNA fragment was gel-purified and
subjected to PeR sequencing. Comparison of the genomic DNA
sequence. the eDNA sequence and the amino acid sequanr.e,
revealed that this VT dipeptide deletion site is located at
an exonl intron boundary ( Figure 14 ,IS ). By comparison with
consensus sequences for 5' splice donor and 3' splic(~
acceptor, I predict that alternative splicing caused thi:> VT
deletion in XFGFR-A3.
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Figure 13. RT-PCR assay of XFGFR-A2 expression using Px-l and
Px-2 oligonucleotide primers. cDNAs from six different stage
xenopus embryos, along with the XFGFR-A2 plasmid, were PCR
amplified with Px-l and Px-2 primers ( recognize the XFGFR-A2
sequence only) or with T305 and 5402 primers ( to recognize
all the XFGFR-ll fig variants). T305 and 5402 primers are
used as a PCR amplification control. PCR were performed as
described in Materials and Methods. Total RNA was isolated
from different stage xenopus embryos and cDNA was synthesized
using oligo ( dT ) priming method. Following 32 cycles of peR
amplification, 10 % of each PCR product was run on a 2 %
agarose gel in lxTBE buffer. The results indicated XFGFR-A2
was also expressed in all stages of xenopus embryos. Lane 1,
3, 5, 7, 9 and 11 are RT-PCR products from stage 2, 6, 8, 24,
30 and 41 embryos with T305 and 5402 as primers. Lane 2, 4,
6, 8, 10 and 12 are PCR products from stage 2, 6, 8, 24, 30
and 41 embryos with Px-l and Px-2 as primers. Lane 13 is RT-
PCR product from XFGFR-A3 plasmid with T305 and 5402 as
primers. Lane 14 is RT-PCR product from XFGFR-A3 plasmid with
Px-l and Px-2 as primers. Lane 15 is 1 Kb ladder DNA size
markers.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
...
-154
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Figure 14. Genomic DNA PeR ilpp1'Oach to charactel"ize Vc,l"I~'­
Thr4J4 deletion reg ion of XFGFR-A3.
Figure 14A. Schematic diagram of the genomic PeR method. 'I'lle
PeR primers are constructed based on exon sequences. If the
genomic sequence contains one or mOJ."e iot1'ons between the
primer sequences, the PeR products from the cDNA templclce
will be smaller than than peR products derived from the
genomic DNA.
Primer 1
--------&~.I
Exon 1 Intron
Primer 2
7?'WA--
Exon 2
eDNA PCR Product ~-----Genomic DNA PCR Product
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Figure 148. Comparison of PeR-amplified XFGFR-ll fig fragment
from Xenopus cDNA Libraries ( lane 2 and 3 ) and genomic DNA
libraries ( Lane 1 ). Lane 4 contains 1 kb ladder DNA size
markers. PeR primers are T30S and 5402 which span a intron in
FGFR11 fig genomic DNA. The PeR amplified genomic DNA fragment
is 1.4 kb while the eDNA fragment is 330 bp.
1 2
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Figure 15, XFGFRI-A) genomic DNA sequences spallning the Vi1l~~·L
Thr~~~ deletion region. The nucleotide sequences of XFGFH-A)
genomic fragment containing Val~·~J-ThrJ·~·1 deletion are $1101>111 in
bold. Exon sequences are shown in uppercase and intron
sequences are shown in lowercase. Corresponding amino dcid
sequence is also shown. The nucleotides with asterisk
indicate the alterna.tive 5' splice donor sites involved in
the alternative splicing process to generate the V~,1'1.~·1-1'IH··I.:,\
deletion.
eTa cae AGA ';AC<;Itl","c"~'""""J'.,"ltn~~YoJ'JtLl",·.. ,'.'".,,"j ~,_, .,,",,'" '1".•. "",.,,:'1'1' 1,'A ,;.,: ,:1\,'
~ R R \i v l'
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Figure 16. Stained protein gel showing expression of GEX-
FGFR(VT+), GEX-FGFR(VT-) fusion protein and GST. Lane 1 is
molecular-weight marker for size indication. Lane 2 and 3 are
GST protein after elution from glutathione-agarose beads.
lane 4 and 5 are GEX-FGFR(VT+) fusion pretein after elution
from glutathione-agarose beads. Lane 6 and 7 are GEX-FGFR (VT-
) fusion protein after elution from glutathione-agarose
beads. Lane 9 and 10 are the total cell lysate of pGEX-KT
transformant after IPTG induction. Lane 11 and 12 are the
total cell lysate of pGEX-FGFR(VT+) transformant after IPTG
induction. Lane 13 and 14 are the total cell lysate of pGEX-
FGFR(VT-) transformant after IPTG induction. Lane 15 is
molecular-weight marker for size indication.
t 2 3 4 5 6 7 8 9 10 11 12 13 14-, 15
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Table 7. Results from PKC assay.
Total Jcp
incorporation
(CPM/nmol protein)
PKC-speci f ic
incorporation
(CPM/nmol protl'.!in)
GEX-FGFR(VT+l 12,885 6,457
GEX-FGFR(VT+}+
PKC inhibitor 6,428
GEX-FGFR(VT-) 7,011
GEX-FGFR(VT-l+
PKC inhibitor 8,161
107
3.7. PKC Assay Results of GST-FGFR{VT+) and
GST-FGFR{VT-) fusion proteins
The GST-FGFR(VT-) and GST-FG'FR(VT+) fusion proteins were
pI,.. -Hied as outlined in Methods ( 2.2.13.2 ), The purity of
the fusion protein was analyzed on 50S-PAGE ( Figure 16 ),
There were contaminants, But for preliminary in vitro
phosphorylation assay, I only wished to see if there was a
difference bet..,een the two fusion protein preparations. Thr424
of XFGFR1 is contained within a consensus phosphorlyation
site for PKC ( Kennelly and Krebs 1991 ). PKC requires basic
amino Clcid residues near the phosphoac:,eptor group, PKC can
be influenced by both l'l- and C- terminal basic residues, The,'·
sites of phosphorylation contains at least one arginine or
lysine at position -1 through -3. Some possessed one or more
at position +1 through +3. Arginine has been observed
superior to lysine. The consensus sequences for PRe is given
as R!O'l_.!'x>,,) S*!T*(X>l"R!K l _)). Where two amino acids
function interchangeably, both are listed with a slash .. I ..
separating them. Sequence position judged to be recognition
neutral are denoted by an x. The phosphoacceptor amino acid
is denoted by an asterisk. T., test the possibility that Thr4N
can be phosphorylated by PKC, I made two constructs using a
portion of the juxtamembrane region of FGFR ( detailed in
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Methods 2.2.13 1. Construct pGEX-FGFR(VT-) expressed tile
fusion protein GST-FGFR(VT-} with VaI4':·'-Thr·I.~'1 dipeptide
deletion in the FGFR region while fusion protein expressed by
the other construct pGEX-FGFR(VT+) had Val·I':.l·Thr~·~,1 in FGFR
region. Protein Kinase C ASsay System ( GIBCO-BRL ) and
purified PKC ( GIBCO-BRL ) were used to measure the
phosphorylation level of both GST fusion protein. The primary
PRC assay result is shown in Table 7. PKC-specific "~P
incorporation in GST-FGFR(VT+} was ,457 cpm/nmol protein.
Almost no l~p incorporation was observed in GST-FGFR(VT-l with
the presence of two extra threonine residues ( Table 7 ).
There were little amount of contaminating proteins in the
preparation. So that at this point, I cannot eliminate the
possibility that the observed phosphorylation was of a
protein other than the fusion protein. Future experiment:>
demand better purification of the fusion proteins. The$e
prelimary data indicate that Thr4~~ is a potential PKC
phosphorylation site.
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Chapter 4
niscussion
4.1. Regulation of Mesoderm Formation by the
FGF /FGFR Signalling System
Available evidenc~ suggests that FGF plays an important
role during mesoderm induction in Xenopus embryonic
development (Slack et al, 1987; Gillespie et a!, 1989; Amaya
et al, 1991; Ryan and Gillespie, Submitted). It has been
shown that not only can FGF induce ruesoderm formation but
also different concentrations of FGF induce different
mesoderm tissues ( Smith and Slack 1983; Slack. et a1., 1984
; Slack et aI, 1987; Gillespie et aI, 1989; Kimelman. et al.,
1992 ). Therefore, it is very important to understand how the
different responses can be mediated by FGF/FGFR signaling
system during the mesoderm induction process.
There are several possible mechanisms which FGF/FGFR
sign1l11ing system might use to generate different
intr1lcellular signals to induce differcmtiation into d::':Jtinct
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mesodermal cell types: 1) The activation of FGFRs might
depend on the availability of the appropriate FCF family
members ( Giordano et al .• 1992 I. Since all members of the
FGF family bind to the extracellula.r matrix. theit'
distribution is likely to be restricted to the aloe,)
surrounding the cells that produce them ( Klagsbrun et <11 .•
1986 l. The distribution of the FGFs during embryonic
development have been studied in several species ( Goldfarb.
1990 ). RNAs for aFGF and bFGF have been detected in mouse
embryo throughout gestation. RNAs for aFGf and bFGP hdve also
been found in blastula stage amphibian embryos. The most
throughly characterized expression profile for FGF genes is
that of murine int-2. int-2 RNA is expressed throughout
embryogenesis and at birth but not in any adult ti::;sues. The
murine FCFS and FGF6 genes are expressed throughout
embryogenesis as well as in restricted sets of adult tissues.
It is possible that the activation of PGE" receptors in
embryos can be regulated by the .:1vailability of the
appropriate f'GF ligand I Giordano et al., 1992 I. 2) FGF/FGFR
signalling system can generate dif ferent intracellul ar
signals by regulating the availability of various members of
the FGFR family in different cells or embryonic tissues (
Pats tone et al., 1993 ). The distribution of F'GF' receptors
during development had been char<lcterized in humiln and oth~r
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species by in situ hybridization. FGFR1 was found highly
expressed in the skin, brain, and bone of chickens, mice, and
humans embryos ( Wanaka et a1., 1991; Safran et a1., 1990;
Partanen et a1., 1991 l. The human FGFR 2 genes were
expressed at high levels in skin and other epithelial cells (
Peters et a1., 1992 ). FGFRJ, which is closely related to
fGFR2. was localized to human fetal brain, skin, bones,
intestine, and lung ( Partanen et a1., 1991 ). FGFR4 was
shown to be expressed at high level in the adrenal and lung (
Partanen et 011., 1991 ). Gillespie et a1., ( 1989 ) provided
evidence that all cells of the Xenopus blastula have high
affinity binding sites for radioiodinated FGF. In addtion,
the FGF/FGF'R complex was phosphorylated on tyrosine residues
in FGF treated Xencpus blastula cells ( Gillespie et a1.,
1992 As in other receptor tyrosine kinases,
phosphorylation on tyrosine residues may activates the FGF'R.
It means that each of the FGF'Rs has a different biological
role and highlights the importance of the spatial and
temporal distribution of FGF'Rs in tissues and amphibian
embryos in mediating different cellular responses. J) The FGF
receptors might mediate different cellular responses
depending on the composition of the FGF receptor oligomer
formed. Both FGFR1 and FGFR2 have the alternatively spliced
isoforms with two rg-like domain in the extracellular region
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of the receptor. These isoforms have diffet"ent ligand binding
specificities ( Werner et a1., 1992; Dionne et ,'11., 1990 )"
In addition, the subtle differences in FCF receptOl
cytoplasmic domains might be responsible for the genel'<ltiC'l'
of different intracellular signals and cause diEfet"ell"
cellular responses. 4) The present of other molecules, such
as Wnt and Noggin family members, can also synergize with
FCFs and change the cell responses to FOFI rorR signalling
system ( Christian et a1., 1992 )" It is also importClnt to
emphasize that probably each one of the four possibilities
mentioned above has a role to play" By combining one or mo!"e
of the mechanisms, the cellular response may bl;! ~fine tuned"
The end result would be an "infinite" variety of cellular
responses to FGF.
4.2. Expression of the FGFRl Isoforms during
Xenopus Development
Our interest was to investigate the relationship betwer~n
the expression of different FGFRS al"d mesoderm induction in
Xenopus. Up to now, cDNA clones of the FGFrn ( XFGFR-Al and
XFGFR-A2 1 were isolated from the XTC cell I ine or from
oocytes ( Musci et a1., 1990; Friesel and Da'l,id, 1991 l. To
study the role of the PGFR in Xenopus embryonic devf':!opmp.nt,
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especially in mesoderm induction events, It was necessary to
isolat~ PGFR eDNA clones from blastula stage, when mesoderm
induction is known to occur. Therefore I constructed a cDNA
library with mRMA from blastula stage ( Stage 8 ) Xenopus
embryos and isolated a full-length PGPR1 eDNA clone from it.
The XFGPR cDNA clone isolated in our laboratory has been
designated XPGPR-AJ ( Chen ee 031., manuscript in preparation
1. XF'GF'R-AJ eDNA is a FGFRI ( £1g ) variant of the previously
identified Xenopus FGFR11 £1g ( Musci et 031., 1990 ) with the
exception of two dipeptide deletions in the juxtamembrane
region. The first is a Thr~~NaI4~4 ( VT ) deletion and the
second is Pro4.IISer14~ ( PS ). The PS deletion has been
previously reported in Xenopus { F'riesel and Dawid, 1991 1,
however, eDNA cloning and expression studies of the VT
dipeptide deleted F'GF'R1 in Xenopus has not. "A similar human
F'GF'R1 variant has been isolated from live cell and the
possible function of Thr·l~4 has been speculated ( Hou et al.,
1991 }. Elucidation of the expression pattern of this FGF'Rl
variant in Xenopus embryos is a important step toward
understanding the effects of this variant on Xenopus
embryoni c development.
We performed a Quantitative analysis of XF'GF'R-A3 ( VT
deleted ) and XFGFR-A2 ( non-deleted ) mRNA expression
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during the Xenopus early development. Both RNase protection
and RT-PCR were performed to detect XFGFR-A3 and XFGFR-1\2
mRNA expression in Xenopus embryos. RT-peR is an extrem81y
sensitive method to detect specific mRNAs. This technique is
very useful for rapid and simultaneous analysis oC several
different gene transcripts or alternative splicing products
with only a few micrograms of total RNA ( Hongjun et ,~1.,
1990 l. RNase protection is a reliable and sensitive method
for quantitating mRNA expression. Both XFGFR-A] and XFGFR-A2
mRNA were shown to be expressed uniformly throughout etldy
developmental stages ( Figure 9, 10, 11 I. The unifol'm
expression itself may mean both XFGFR-A] and XFGFR-A2 htlve
important functions during Xenopus embryonic dev£!lopmenL. The
RNase protection experiment also showed thtlt there was no
antisense XFGFR-A3 RNA presence in the xenopus embryos ( Dtlta
not shown I. Therefore, the control of the XFGFR-A3 function
by ,:o-expression of a complementtlry RNA molecule is unlikely
to play an important role.
4.3. Regulation of FGFRl Activity by PKe
Thr4~4 of XFGFRI may serve as tl phosphorylation site by a
serine-threonine kinase ( Hou et ill., 1991 l and our in vitro
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phosphorylation assay supports this hypothesis ( Table 7 l.
The results demonstrate that only the non deleted isoform was
phosphorylated by PKC in vitro This PRC assay is a
preliminary data which was performed with purified entire
fusion protein. Because the purified fusion protein sample (
Figure 16 ) contain; some contaminating bacterial proteins,
we plan to repeat this experiment using a synthetic peptide
to verify this result. Also, this preliminary data does not
provide information about which residue is phosphorylated. We
will do phosphorylated amino acid analysis on the
phosphorylated fusion protein to determine which residue is
phosphorylated. Additional PKe assays should be performed
with the cleaved F'GFR portion instead of whole fusion
protein. It is important to determine the effect of
phosphorylation of Thr~~4 on biological activity of the FGFR.
These experiments involve expressing either XFGFR-A2 or XFGFR-
1'.3 in a cell line that lacks endogenous FGFRs. One can
activates PKC with TPA in thus transformed cell and measure
its effect on FGF binding and tyrosine kinase activity. This
in vivo study can give us more information regarding the
phosphorylation of Thr~J4 residue and its influence on the
biological activity of the FGFR.
Because our clone was isolated from a stage specific eDNA
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library, it suggests the possibility that this potential
phosphorylation site may have important consequences fm
signal transc:.uction as in the case of EGF receptor ( Ullrich
and schlessinger 1990 ). In the EGFR, it has been shown that
PKC and other protein kinases can stimulate the
phosphorylation of threonine6~4 ( Thr6~·1 1 located in the
juxtamembrane region of EGF receptor ( Lin et al., 1986.
Davis and Czech, 19B7 l. Phosphorylation of thic Thr"'''1
phosphorylation results in the lost of high affinity binding
for EGF and a decrease in tyrosine kinase activity. Therefore
PKC serves as a negative regulator of EGE"/EGFR signalling
system. Any growth factor that can stimulate PKC activity
will be able to down regulat.e EGFR activity, a process cdiled
transmodulation ( Ullrich and Schlessinger 1990 }.
Protein kinase C ( PKC ) is also activated during Xenopus
mesoderm induction inducti on by FGF ( Gillespie eC a1., 1992
). Howevel. l.ctivation of PKC in turn inhibits mesoderm
induction by FGE" suggesting that PKC involved in a negative
feedback of FGE"/FGFR :;ignal11ng system as in the case of
EGE"/EGFR system. Therefore, Thr~~'l may be a very important
residue for regulating the E"GE" response during Xenopus
mesoderm induction. It means that the VT deleted E"GFRl would
escape a negative feedback hence have a different impilct on
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mesoderm induction. Different concentrations of pGp induce
different mesodermeral tissues. Expressing a pGpR1 isoform
that is not being turn off by PKC might be equivalent to
using a higher concentration of pGp. Therefore, it is
possible that the VT-de1eted isoform expression is restricted
to a sub-population of cells in blastula stage embryo,
resulting in the generation of a different intracellular
response.
4.4. Mechanism for Generating the FGFRl Isoform
We propose that the VT dipeptide deletion was caused by the
use of an alternative splice donor based on our genomic
sequence analysis ( Figure 12 ) and comparison to the cDNA
and predicted amino acid sequences. This VT dipeptide is
located in the juxtarnembrane region and at the junction site
between exon 8 and exon 9 in the human FGFR ( Johnson et al.,
1991 ). Our data redefined the boundary between exon 8 and
the downstream intron. According to our 'xlUndary sequence,
the dipeptide deletion was VT not TV as has been previously
reported ( Johnson et 031 , 1991; Hou et al., 1991 ). splicing
is essential for the production of mature mRNAs, and
according to the known intron/exon splicing mechanism and
conserved splicing sequences, The VT deleted XFGFRl form
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should be the dominant product ( Figure 12 ). But the non-
rleleted XFGFRl form is in fact the majol" product in Xe:lOplIs
embryos. Its mRNA accounts for more than 95 % of thf:l \'1tnle
FGFR1 mRNA population while the deleted form constitutes les:::
than 5 %. We propose that some secondary structure was
formed as guiding sequence to stablize the splicing
intermediate and results in the use of illternate splicing
site which will yields the non deleted form XFGF'R1.
4.5. FGFRl Isoforms and Mesoderm Induction in
Xenopus Embryos
The least conserved regions of RTK are the juxtamernbrane
region. the C-terminus. and the kinase insert sequences. It
has already been shown that in other receptor tyrosine kinase
the latter two regions are involved in the substrate
specificity. ( Cantley ~t 031.. 1991 ). The juxtamembrc)ne
region. on the other hand, is involved in modulation of
receptor function by heterologous stimuli. or receptor
transmodulation. It h.:is been shown that co-expression of <)
truncated FGFR1 lacking most of its cytosolic region blocked
bFGF-induced signal transduction by the wild-type F(WR ( Ueno
et al., 1992 ). It also has been shown that over expression
of a dominant negative form of FGFR1 ( cytoplasmic region
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truncated) can block signal transduction by FGFR1, FGFR2 and
several other family members { Amaya et ai., 1991 ). The
minimum amount of truncated FGFR 1 protein necessary to block
most of the wild-type receptor response is somewhere between
10 to 75 times over the amount of wild-type receptor protein.
The most likely explanation is that truncated FGFRs form
heterodimers with wild-type FGFRs. This heterodimer is
defective in autophosphorylation ( Rashles et ai., 1991 ),
and hence blocks signal transduction. It is possible that in
cells that express more than one variant of wild-type FGFRl,
signal transduction may occur through different variant
heterodimers as well as through homodimers. Evidence suggests
that in cells expressing several types of FGFRs, FGFR
heterodimers and homodimers may activate the cytoplasmic
signalling pathway differently ( Ueno ec ai., 1992 ). This
has led to the proposal that on the cell surface. all FGFR
family members can interact with each othet" and that both
homodimer and heterodimers are formed in order to carry out
their pleiotropic functions.
At present, four members of the FGP family ( aFGF. bFGF,
hst/K-FGF and int-2 ) have been shown to have mesoderm-
inducing activity ( Slack et ai., 1987; Paterno et ai., 1989
) . It has been suggested that FGFs and/or other mesoderm
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inducing signals are relased from the vegetal hemisphel"e 01"
from within the marginal zone, and induce the mesoderTll at the."
equator of the embryo ( Smith and Slack 1983; Slack. et ..11.,
1984 ; Slack et al. 1987 I. Different types of cells l1<\ve
different responses to FCF. One explanation is thJt the
availability of different members of FCFR family dnd t.hel."
variants are regulated during the mesoderm induction process.
So far, only the expression patterns of FGFRI and FCFR2 have
been reported 1 Yamaguchi et al., 1992, Friesel and o.."lwid
1991, Friese1 and Brown 1992 l. FGrRI rnRNA is llnifor:1!I1y
expressed at a high level throughout XerlopuS eddy
developmental stages" This observation is in cll]reement wi tit
the timing of mesoderm induction. FGFR2. on the other h~llld.
has been found only expressed after gastrulation st<lO]f:S I
Friesel and Brown 1992 ,. This could mean that FGrRl has ,In
important function in the mesoderm induction proces!:: whi Ie
FGFR2 has a role in late stages of embryonic development.
However, this data can not distinguish between FGFR isoforms.
Di f ferent isoforms may have unique expression pat terns dill.!
specific functions.
The absence of the VaI4~J-Thr4~·1 in Y.FGFR-AJ may not pLay iJ
direct structural role but instead /Oily regulilte th~
availability of a phosphorylation site. Findinqs frOln othr:r
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research groups ( 'T'empelton and Hauschka, 1992 ) demonstrated
that several alternatively spliced variants of FGFRl involved
in skeletal muscle cell proliferation and in the repression
of terminal differentiation. Like the differential splicing
in the extr"lcellular region of FGFRI can generate receptor
variants with different ligand binding specificities ( Werner
1992 ), the differential splicing in the juxtamembrane region
could serve to diversify the intracellular responses caused
by FGF/FGFR signal] ing system. Therefore it is possible that
the intracellular signal transduction pathways activated by
FGF/FGFR were changed during mesoderm induction and XFGFR-A]
may have a different function in embryogenesis. In this
regard, a RNase protection experiment to determine the
spatial distribution of XFGFR-A] in Xenopus embryos will be
very useful.
In the future, we can do in situ hybridization to look at
localization of XFGfR-A2 and XFGFR-A] in Xenopus embryos as
well as use RNase protection aGsay. To further investigate
the phosphorylation state of Thr4~' in XFGFR-A2, we can use
GST-cleaved fusion protein to do the PKC assay or use
synthetic peptides to do it. We can also separately express
XFGFR-A2 and XFGFR-A] in a cell line that lacks endogenous
FGFRs and analyze the cell's response to XFGFR-A2 and XFGF-A]
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expression. These experiments \frIill give us more infot-mation
about the role that XFGFR-AJ and XFGFR-A2 played in XeJ10pUS
development.
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